Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3052649	s-ada	u/l (u/l)	2601	3624	1.52%
3052649	s-ada	— (—)	194	226	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

COPD differential diagnosis

545

275

10.01

320.21

1.5

1.3

12.24

12.56

u/l

0.28

528

268

ILD differential diagnosis

545

275

10.01

320.19

1.5

1.3

12.24

12.56

u/l

0.28

528

268

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

467

503

8.09

314.71

1.4

10.89

13.57

u/l

12.08

450

480

Other pleural conditions

605

117

60.54

307.65

1.6

1.3

12.62

14.13

u/l

1.16

584

109

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

935

1067

5.57

307.65

1.5

1.4

12.79

12.18

u/l

1.33

899

1041

Pneumonia, organism unspecified

956

1286

5.45

307.65

1.5

1.4

12.79

12.32

u/l

0.94

918

1254

Pleural effusion

1199

189

78.05

307.65

1.5

1.3

12.55

14.10

u/l

1.64

1170

177

Other pulmonary diagnosis

568

273

10.52

307.65

1.5

1.3

12.21

12.45

u/l

0.21

547

266

Pneumonias (Asthma/COPD co-morbidities)

1004

1366

5.16

307.65

1.5

1.4

12.76

12.28

u/l

1.01

962

1333

Excluding asthma or asthma-COPD overlap

552

273

10.22

307.65

1.5

1.3

12.25

12.45

u/l

0.17

535

266

935

1067

5.57

307.65

1.5

1.4

12.79

12.18

u/l

1.33

899

1041

All pneumoniae

1005

1365

5.15

307.65

1.5

1.4

12.77

12.30

u/l

0.97

963

1332

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

994

1380

5.13

307.65

1.5

1.4

12.82

12.31

u/l

1.10

952

1347

Other diseases of pleura

1536

575

25.43

307.65

1.5

1.3

12.58

13.82

u/l

2.89

1489

551

Influenza and pneumonia

1006

1337

5.01

307.65

1.5

1.4

12.75

12.26

u/l

1.02

965

1304

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

727

1547

4.43

280.45

1.5

1.4

12.68

13.06

u/l

0.66

699

1490

Abnormal findings on diagnostic imaging of lung

631

1277

4.92

280.05

1.5

1.4

12.69

13.34

u/l

1.31

607

1231

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

911

1669

3.96

280.00

1.6

1.3

13.68

12.19

u/l

5.77

880

1612

Asthma, unspecified (mode)

333

255

10.45

266.06

1.4

1.3

12.24

12.43

u/l

0.14

323

248

Heart failure, not strict

742

1145

4.53

265.72

1.5

1.4

13.84

11.69

u/l

10.29

707

1118

Bacterial infection, other or unspecified

625

1189

4.83

265.38

1.5

1.4

13.94

12.46

u/l

3.76

594

1149

Asthma

455

273

9.01

262.65

1.5

1.3

12.05

12.45

u/l

0.37

440

266

Other bacterial diseases

872

1550

3.93

262.64

1.5

1.4

13.69

12.07

u/l

6.65

839

1503

Asthma (only as main-diagnosis)

411

273

9.15

257.50

1.5

1.3

12.24

12.45

u/l

0.17

399

266

Suppurative and necrotic conditions of lower respiratory tract

215

134

17.84

257.15

1.6

1.4

11.51

14.37

u/l

3.25

207

125

Heart failure,strict

612

890

5.06

251.81

1.5

1.3

14.51

11.85

u/l

11.99

588

864

Pyothorax

190

102

21.15

244.81

1.6

1.4

11.45

14.02

u/l

3.01

182

Asthma (mode)

428

275

8.61

243.62

1.5

1.3

12.08

12.56

u/l

0.44

415

268

Heart failure, strict

663

1174

4.14

215.34

1.5

1.4

14.57

12.30

u/l

9.77

636

1128

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

356

436

7.04

213.59

1.3

1.4

11.12

13.75

u/l

9.79

343

416

All-cause Heart Failure

641

1158

4.06

203.27

1.5

1.4

14.53

12.30

u/l

9.22

613

1112

Dyspnoea

772

1740

3.43

198.71

1.5

1.4

12.77

u/l

0.00

746

1680

Fever of other and unknown origin

541

1214

4.19

194.91

1.5

1.4

13.50

12.46

u/l

2.09

518

1178

Certain disorders involving the immune mechanism

291

415

7.23

193.68

2.0

1.4

13.19

12.18

u/l

1.13

286

400

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

270

327

8.07

192.09

1.3

1.4

10.75

13.72

u/l

9.37

259

311

Malignant neoplasm of respiratory system and intrathoracic organs

380

651

5.55

188.20

1.4

10.69

13.89

u/l

17.89

368

621

Diseases of the respiratory system

381

269

7.15

180.62

1.5

1.2

12.48

12.69

u/l

0.16

366

262

First line medication for Crohn's disease

834

1399

3.28

178.87

1.5

1.4

12.62

12.72

u/l

0.13

805

1350

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

427

796

4.79

178.49

1.4

1.5

11.92

13.42

u/l

3.31

411

764

Heart failure and antihypertensive medication

317

300

7.13

173.31

1.6

1.4

14.30

10.85

u/l

9.45

302

289

Oral corticosteroids

834

1625

3.13

172.83

1.5

1.4

12.63

12.64

u/l

0.01

804

1569

Other medical care

453

1043

4.32

172.03

1.5

1.4

11.79

13.12

u/l

3.31

439

1009

ILD medications: prednisolone, methylprednisolone, prednisone

842

1528

3.14

171.12

1.5

1.4

12.72

12.46

u/l

0.42

812

1478

COPD/asthma related infections

736

1067

3.48

166.73

1.5

1.4

12.74

12.18

u/l

1.00

707

1041

COPD/asthma/ILD related infections

736

1067

3.48

166.73

1.5

1.4

12.74

12.18

u/l

1.00

707

1041

Inflammatory bowel disease treatment related agents

858

1645

2.99

161.17

1.5

1.4

12.75

12.62

u/l

0.17

829

1589

Nonhereditary hypogammaglobulinemia

75.22

159.06

3.1

1.5

13.87

12.20

u/l

0.51

Abnormalities of breathing

671

1209

3.32

151.80

1.5

1.4

12.45

12.48

u/l

0.03

647

1177

ILD medications

823

1537

2.96

150.77

1.5

1.4

12.93

12.45

u/l

0.88

792

1487

Bacterial Sepsis

471

1138

3.74

143.36

1.6

1.4

14.62

12.64

u/l

5.56

448

1101

Non-small cell lung cancer

270

504

5.54

137.55

1.3

1.4

10.75

13.71

u/l

11.85

259

483

Bacterial pneumonia, not elsewhere classified

366

759

4.33

135.84

1.5

1.4

13.09

12.68

u/l

0.46

350

741

Bacterial pneumoniae

372

784

4.26

135.27

1.5

1.4

13.04

12.66

u/l

0.43

355

766

Septicaemia

399

1002

3.89

131.33

1.5

1.4

14.71

12.56

u/l

5.57

380

966

Anaemias

172

103

11.22

129.45

1.6

1.5

14.59

11.05

u/l

3.75

165

103

Oxycodone

374

915

4.02

129.01

1.5

1.4

12.25

12.96

u/l

0.90

357

877

Implicit bacterial Sepsis

418

1039

3.75

128.80

1.6

1.4

14.75

12.67

u/l

5.22

395

1005

Renal tubulo-interstitial diseases

660

1764

2.89

128.76

1.5

1.4

14.07

12.23

u/l

7.38

630

1711

Persons encountering health services for specific procedures and health care

739

1641

2.81

128.73

1.5

1.4

12.74

12.49

u/l

0.34

707

1595

Implicit Sepsis

588

1510

3.06

126.53

1.5

1.4

14.06

12.32

u/l

5.74

558

1464

Non-ischemic cardiomyopathy

332

633

4.39

121.83

1.6

1.3

13.79

12.36

u/l

2.70

315

609

GASTRO-related operations

458

598

3.86

119.82

1.6

1.3

12.57

11.90

u/l

1.04

445

569

Any gastric operation

458

598

3.86

119.82

1.6

1.3

12.57

11.90

u/l

1.04

445

569

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

127

118

11.33

119.11

1.3

10.29

13.89

u/l

6.71

118

112

Explicit Sepsis

405

1115

3.53

115.91

1.5

1.4

14.83

12.59

u/l

5.82

386

1079

Other heart diseases, wide

564

1144

3.08

115.16

1.5

1.4

12.78

11.52

u/l

3.45

543

1112

Other septicaemia

355

926

3.82

114.71

1.6

1.4

14.60

12.59

u/l

4.36

338

892

Renal failure

447

1283

3.23

109.77

1.5

1.4

15.12

12.86

u/l

7.10

421

1239

Other heart diseases

300

450

4.44

104.07

1.5

1.4

12.84

11.03

u/l

3.15

288

441

Malignant neoplasm of bronchus and lung

272

603

4.33

101.90

1.3

1.4

10.89

13.73

u/l

12.17

263

576

Certain infectious and parasitic diseases

613

1107

2.79

98.63

1.6

1.4

13.25

11.68

u/l

5.32

594

1075

ILD medications: immunosuppressive drugs

401

1214

3.19

98.53

1.5

1.4

14.36

12.22

u/l

4.42

384

1178

Asthma-related pneumonia

343

1018

3.41

94.22

1.5

1.4

12.54

13.15

u/l

0.89

331

978

Heart failure and bmi 25plus

332

618

3.76

94.19

1.5

1.4

14.95

12.48

u/l

6.08

317

591

Asthma-related pneumonia or sepsis

343

1021

3.40

93.78

1.5

1.4

12.54

13.17

u/l

0.93

331

981

Asthma, hospital admissions 3, pneumonia

343

1021

3.40

93.78

1.5

1.4

12.54

13.17

u/l

0.93

331

981

Primary_lymphoid and hematopoietic malignant neoplasms

223

493

4.60

92.83

1.6

1.4

16.27

13.50

u/l

3.06

214

471

Condition for Implicit Sepsis (Organ dysfunction codes)

576

1605

2.63

92.74

1.5

1.4

13.66

12.20

u/l

4.22

546

1559

General symptoms and signs

684

1365

2.52

91.50

1.5

1.4

12.79

12.34

u/l

0.76

654

1327

Valvular heart disease excluding rheumatic fever

352

753

3.45

90.42

1.6

1.4

14.37

11.77

u/l

7.20

337

725

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

534

1144

2.78

90.14

1.5

1.4

11.95

12.93

u/l

2.27

516

1106

Non-rheumatic valve diseases

351

751

3.45

89.98

1.6

1.4

14.42

11.78

u/l

7.38

336

723

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

533

1143

2.77

89.79

1.5

1.4

11.93

12.93

u/l

2.34

515

1105

Malignant neoplasm, wide definition for exclusion

533

1144

2.77

89.66

1.5

1.4

11.93

12.94

u/l

2.36

515

1106

Non-small cell lung cancer, adenocarcinoma

127

176

7.58

87.34

1.3

1.4

10.29

13.72

u/l

6.34

118

166

Non-small cell lung cancer, adenocarcinoma, helper endpoint

127

176

7.58

87.34

1.3

1.4

10.29

13.72

u/l

6.34

118

166

Bacterial pneumonia (organism specified)

397

1222

2.99

85.97

1.5

1.4

13.15

12.93

u/l

0.24

379

1183

Acute renal failure

228

555

4.19

84.07

1.5

1.4

14.86

12.71

u/l

4.13

216

534

Non-invasive ventilation

166

287

5.50

83.63

1.5

1.3

11.59

11.05

u/l

0.47

158

278

Chronic kidney disease

308

921

3.38

83.30

1.5

1.4

15.46

13.15

u/l

4.85

290

889

Dialysis, with operation codes

162

304

5.47

82.08

1.5

1.4

14.92

12.67

u/l

2.70

153

294

Asthma-related infections

428

1539

2.76

81.56

1.5

1.4

12.43

12.93

u/l

0.73

415

1487

Asthma, hospital admission 2, infections

428

1539

2.76

81.56

1.5

1.4

12.43

12.93

u/l

0.73

415

1487

Malignant neoplasm

531

1210

2.62

80.55

1.5

1.4

12.05

12.89

u/l

1.75

515

1169

COPD

408

1183

2.88

80.41

1.5

1.4

12.47

13.26

u/l

1.60

392

1141

Atrial fibrillation and flutter

218

309

4.65

79.46

1.4

13.58

11.16

u/l

3.78

208

300

Chronic lower respiratory diseases

734

1773

2.25

78.80

1.5

1.4

12.11

12.86

u/l

1.96

709

1714

Other chronic obstructive pulmonary disease

390

1151

2.85

75.72

1.5

1.4

12.53

13.29

u/l

1.47

374

1109

Nephropathy related operations

155

302

5.27

75.35

1.5

1.4

14.89

12.72

u/l

2.37

146

290

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

201

494

4.14

73.12

1.3

1.4

10.97

13.24

u/l

6.44

193

474

Aplastic and other anaemias

385

1354

2.73

70.99

1.5

1.4

14.51

13.01

u/l

2.59

366

1304

Atrial fibrillation and flutter with reimbursement

190

266

4.63

68.42

1.5

1.4

13.87

11.08

u/l

4.48

180

258

All influenza

181

434

4.22

67.95

1.7

1.5

13.38

12.46

u/l

0.87

176

426

Symptoms and signs involving the circulatory and respiratory systems

565

1212

2.35

65.34

1.5

1.4

12.38

12.48

u/l

0.11

543

1180

Any event in cancer register

512

1275

2.39

64.93

1.5

1.4

11.76

12.89

u/l

3.11

496

1232

Other chronic obstructive pulmonary disease, including avohilmo

433

1459

2.49

64.85

1.5

1.4

12.44

13.31

u/l

2.07

413

1407

Other anaemias

355

1282

2.70

64.63

1.5

1.4

14.27

13.06

u/l

1.76

338

1233

Diseases of arteries, arterioles and capillaries (FINNGEN)

170

258

4.65

63.83

1.5

1.3

13.61

11.15

u/l

3.62

160

250

Erysipelas

366

1269

2.65

63.73

1.5

1.4

13.82

12.43

u/l

3.72

351

1228

COPD, hospital admissions

393

1300

2.59

63.73

1.5

1.4

12.54

13.27

u/l

1.46

377

1252

Other and unspecified anaemias

350

1271

2.69

63.41

1.5

1.4

14.31

13.07

u/l

1.80

333

1222

COPD, early/later onset

395

1310

2.57

63.36

1.5

1.4

12.56

13.25

u/l

1.36

379

1260

Cardiac arrhythmias

324

739

2.91

61.98

1.5

1.4

12.89

10.78

u/l

5.02

311

718

Implicit viral Sepsis

175

441

4.03

61.61

1.7

1.4

14.88

12.52

u/l

2.56

169

427

Viral Sepsis

175

441

4.03

61.61

1.7

1.4

14.88

12.52

u/l

2.56

169

427

Cerebrovascular diseases (FINNGEN)

183

318

4.15

60.55

1.5

1.4

12.98

10.96

u/l

3.04

178

309

COPD, hospital admission 2, with asthma infections

307

927

2.86

60.53

1.5

1.4

12.81

13.42

u/l

0.87

292

888

Metabolic disorders

578

1654

2.18

60.11

1.5

1.4

13.19

12.40

u/l

1.64

561

1595

Malaise and fatigue

334

1036

2.71

59.38

1.4

13.93

12.51

u/l

2.41

318

1009

286

1000

2.86

58.69

1.5

1.4

12.13

12.65

u/l

0.58

279

966

Polyarthropathies

460

1304

2.37

58.67

1.5

1.4

14.05

12.34

u/l

4.21

443

1263

Opioids

557

1316

2.23

58.45

1.5

1.4

12.33

12.62

u/l

0.38

534

1275

Common variable immunodeficiency

159.90

58.11

2.9

1.2

16.07

12.80

u/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

223

691

3.28

57.63

1.6

1.4

16.27

12.47

u/l

5.53

214

661

Autoimmune diseases excluding thyroid diseases

625

1660

2.10

57.37

1.5

1.4

13.91

12.16

u/l

5.82

594

1612

Autoimmune diseases excluding thyroid diseases, strict definition

606

1601

2.12

57.02

1.5

1.4

13.99

12.20

u/l

5.76

576

1555

Benign neoplasm of colon, rectum, anus and anal canal

309

792

2.81

56.53

1.4

1.5

13.36

13.20

u/l

0.15

302

761

Any reimbursement code in KELA

234

330

3.57

55.56

1.7

1.3

12.04

11.28

u/l

0.73

227

325

COPD related to multimorbidity

344

1139

2.57

55.16

1.4

12.92

13.38

u/l

0.68

330

1095

Other disorders of fluid, electrolyte and acid-base balance

242

793

2.98

52.92

1.5

1.4

14.09

12.93

u/l

1.62

232

757

COPD, hospital admissions 3, with asthma pneumonia sepsis

265

795

2.87

52.65

1.5

1.4

12.80

13.52

u/l

1.03

254

760

Tramadol

445

1260

2.28

52.03

1.5

1.4

12.92

12.65

u/l

0.30

428

1219

Codeine

513

1301

2.18

51.47

1.4

13.05

12.61

u/l

0.59

495

1261

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

541

1773

2.08

51.33

1.5

1.4

13.60

12.16

u/l

4.32

520

1716

Other immunodeficiencies

30.89

50.90

2.0

1.8

12.06

11.92

u/l

0.04

Cardiovascular diseases (excluding rheumatic etc)

269

529

2.95

50.52

1.6

1.4

11.98

10.95

u/l

1.24

260

520

Bronchitis

610

2028

1.98

50.13

1.5

1.4

13.03

12.59

u/l

0.72

589

1960

Benign neoplasm: Colon

276

771

2.76

50.07

1.5

13.57

13.14

u/l

0.46

269

740

Parasetamol

437

972

2.30

49.03

1.5

1.4

12.62

12.28

u/l

0.42

420

944

Asthma (diagnoses ohter than nonallergic)

501

2086

2.06

48.72

1.5

1.4

12.12

12.87

u/l

1.67

487

2012

Pulmonary heart disease, diseases of pulmonary circulation

254

937

2.74

48.11

1.4

11.77

13.14

u/l

2.69

246

895

Other respiratory disorders and diseases

192

611

3.19

47.59

1.7

1.4

12.94

13.22

u/l

0.24

185

587

Other diseases of the respiratory system

192

611

3.19

47.59

1.7

1.4

12.94

13.22

u/l

0.24

185

587

Neoplasms

361

789

2.46

47.40

1.7

1.4

12.47

12.64

u/l

0.15

350

766

Haemorrhage from respiratory passages

244

830

2.75

46.00

1.5

1.4

13.65

13.14

u/l

0.47

230

803

628

1724

1.93

45.61

1.5

1.4

12.82

12.62

u/l

0.26

605

1665

Cardiovascular diseases

244

451

2.96

45.27

1.6

1.4

12.00

10.87

u/l

1.29

236

443

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

+∞

44.87

3.1

0.0

18.03

—

u/l

—

Other acute lower respiratory infections

344

1453

2.27

43.62

1.5

1.4

12.89

12.91

u/l

0.02

330

1402

Cardiomyopathy

132

351

3.81

43.21

1.7

1.3

13.43

11.71

u/l

2.29

127

339

Other arrhythmias

313

1002

2.40

43.07

1.4

12.95

11.65

u/l

2.95

307

972

Iron deficiency anaemia

285

1165

2.44

42.76

1.5

1.4

14.14

12.83

u/l

1.86

273

1119

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

110

177

4.65

42.10

1.7

1.3

13.73

11.45

u/l

2.36

105

168

Complications of surgical and medical care, not elsewhere classified

548

2062

1.91

41.73

1.5

1.4

13.19

12.59

u/l

1.19

528

1992

Oedema, not elsewhere classified

206

733

2.82

41.39

1.5

1.4

13.78

12.63

u/l

1.36

198

713

Asthma/COPD (KELA code 203)

494

1769

1.98

41.14

1.4

11.79

12.86

u/l

3.09

477

1710

Pulmonary embolism

224

841

2.69

41.09

1.4

11.47

13.20

u/l

3.58

216

804

Conduction disorders

190

531

3.00

40.90

1.5

1.4

13.99

12.03

u/l

3.30

183

511

Pulmonary heart disease

224

845

2.68

40.71

1.4

11.47

13.21

u/l

3.63

216

808

Pain in throat and chest

411

1190

2.12

39.94

1.5

1.4

12.40

12.49

u/l

0.09

397

1158

Bleeding

492

1846

1.95

39.59

1.5

1.4

14.00

12.60

u/l

3.52

467

1788

L04AX Other immunosuppressants

307

1361

2.27

39.17

1.5

1.4

13.67

12.31

u/l

1.73

295

1321

Benign neoplasms

343

852

2.29

39.17

1.5

1.4

12.45

12.73

u/l

0.27

334

824

Second line medication for Crohn's disease

312

1394

2.25

39.07

1.5

1.4

13.70

12.34

u/l

1.75

300

1352

Diseases of arteries, arterioles and capillaries

441

1645

2.01

39.05

1.4

14.45

12.74

u/l

4.61

421

1582

Acute bronchitis

274

1139

2.37

38.65

1.6

1.4

13.01

13.03

u/l

0.01

264

1097

DVT of lower extremities and pulmonary embolism

294

1286

2.30

38.51

1.4

12.11

13.16

u/l

1.54

280

1237

Acute tubulo-interstitial nephritis

354

1472

2.14

38.47

1.5

1.4

14.23

12.29

u/l

5.27

337

1424

Diseases of the skin and subcutaneous tissue

561

1494

1.89

37.88

1.5

1.4

13.17

12.06

u/l

2.67

539

1452

Autoimmune diseases

598

1664

1.84

37.52

1.5

1.4

13.57

12.14

u/l

4.00

573

1616

Other and unspecified iron deficiency

223

875

2.57

37.43

1.5

1.4

14.09

12.71

u/l

1.58

215

842

Secondary uncertain malignant neoplasm

123

347

3.61

37.08

1.6

1.4

14.92

13.12

u/l

1.04

116

331

Hypertension, essential

391

1061

2.11

37.03

1.6

1.4

13.19

11.47

u/l

4.48

374

1034

Venous thromboembolism

353

1647

2.09

36.65

1.5

1.4

12.22

13.19

u/l

1.62

334

1590

Used for control exclusion in common control thyroid runs

564

1549

1.85

35.99

1.6

1.4

13.11

12.22

u/l

1.99

545

1503

Nutritional anaemias

318

1442

2.16

35.79

1.5

1.4

14.09

12.97

u/l

1.61

305

1389

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

191

423

2.88

35.62

1.7

1.4

13.89

10.89

u/l

4.48

180

414

Chronic periapical parodontitis

156

525

3.00

35.21

1.5

1.4

13.15

12.40

u/l

0.56

146

507

Heart failure and coronary heart disease

287

944

2.29

35.10

1.5

1.4

15.66

13.13

u/l

6.37

275

905

Diseases of pulp and periapical tissues

218

874

2.51

35.01

1.4

12.82

12.49

u/l

0.27

206

848

Hypertensive diseases (excluding secondary)

212

455

2.72

34.82

1.6

1.4

12.72

10.90

u/l

2.49

205

446

Dental caries

174

620

2.80

34.66

1.8

1.4

14.27

12.50

u/l

1.96

168

599

Diseases of oesophagus, stomach and duodenum

565

1912

1.80

34.54

1.5

1.4

13.21

12.42

u/l

1.65

542

1852

Complications of procedures, not elsewhere classified

441

2013

1.90

34.26

1.5

1.4

13.00

12.61

u/l

0.57

426

1943

Dentinal caries

161

559

2.89

34.00

1.8

1.4

14.36

12.31

u/l

2.39

156

538

AV-block

127

347

3.36

33.74

1.4

1.3

14.40

12.03

u/l

3.07

121

335

Presence of cardiac and vascular implants and grafts

330

1187

2.12

33.70

1.5

1.4

14.45

12.75

u/l

4.52

318

1141

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

158

242

3.29

33.69

1.4

12.87

12.08

u/l

0.52

151

235

Intestinal infectious diseases

490

2086

1.83

33.48

1.5

1.4

13.63

12.48

u/l

2.88

468

2021

Codeine or tramadol medication

605

1917

1.75

33.15

1.4

13.32

12.45

u/l

1.92

583

1853

Infections of the skin and subcutaneous tissue

309

1477

2.09

32.37

1.6

1.4

13.45

12.40

u/l

1.52

299

1432

Complications of medical and surgical care

405

2031

1.90

32.05

1.5

1.4

12.96

12.72

u/l

0.29

388

1962

Other special examinations and investigations of persons without complaint or reported diagnosis

373

924

2.05

31.83

1.6

1.4

12.82

12.43

u/l

0.45

362

899

Hypertensive heart and/or renal disease

192

573

2.62

31.76

1.3

1.4

14.29

11.95

u/l

5.73

184

555

Cough

212

840

2.44

31.71

1.7

1.4

12.56

12.61

u/l

0.04

204

817

Diarrhoea and gastroenteritis of presumed infectious origin

365

1700

1.96

31.35

1.5

1.4

13.58

12.50

u/l

1.98

347

1646

Systemic connective tissue disorders

214

900

2.40

31.06

1.5

1.4

13.70

12.85

u/l

0.84

201

867

Asthma, hospital admissions , main diagnosis only

426

2068

1.85

30.79

1.5

1.4

12.18

12.76

u/l

1.00

413

1996

Persons encountering health services in other circumstances, wide

627

1914

1.71

30.72

1.5

1.4

13.02

12.61

u/l

0.69

613

1841

Agranulocytosis

229

3.95

30.70

1.4

12.71

12.83

u/l

0.04

218

Glomerular diseases

144

503

2.90

30.51

1.6

1.4

15.68

12.80

u/l

3.85

135

485

Disorders of lipoprotein metabolism and other lipidaemias

451

1539

1.85

30.31

1.5

1.4

13.54

12.52

u/l

2.09

437

1481

L01XE Protein kinase inhibitors

133

5.02

30.12

1.4

11.20

13.58

u/l

1.99

126

Glomerular disorders in diseases classified elsewhere

103

299

3.50

29.82

1.5

1.4

17.23

12.94

u/l

4.85

289

Examination and observation for other reasons

311

905

2.10

29.61

1.5

1.4

13.04

12.43

u/l

0.66

303

881

Autoimmune diseases related-to ILD

430

2085

1.82

29.39

1.5

1.4

13.34

12.47

u/l

1.52

408

2021

Pacemaker

251

1129

2.18

28.97

1.4

14.47

13.24

u/l

1.99

239

1080

Other disorders of skin and subcutaneous tissue

385

1893

1.87

28.92

1.6

1.4

14.17

12.67

u/l

3.58

359

1840

Type 2 diabetes, wide definition

443

1588

1.83

28.83

1.4

15.14

11.95

u/l

11.87

422

1539

Early onset COPD

163

626

2.63

28.80

1.6

1.4

11.77

12.76

u/l

1.21

158

604

Care involving use of rehabilitation procedures

306

1458

2.00

28.22

1.6

1.4

12.71

u/l

0.00

286

1416

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

268

853

2.16

28.15

1.5

14.13

13.35

u/l

0.79

256

818

Acute upper respiratory infections of multiple and unspecified sites

362

1430

1.90

27.66

1.5

1.4

13.02

12.37

u/l

0.88

353

1378

Asthma, including avohilmo

590

2061

1.67

27.47

1.5

1.4

12.16

12.86

u/l

1.67

571

1990

Medical observation and evaluation for suspected diseases and conditions

354

924

1.97

27.30

1.6

1.4

12.46

12.43

u/l

0.02

341

899

Gout

213

859

2.28

27.15

1.5

1.4

15.00

12.79

u/l

3.65

202

826

Disorders of lens

385

1301

1.88

27.07

1.5

1.4

13.79

12.16

u/l

3.62

364

1258

Other diseases of intestines

522

1773

1.72

27.00

1.5

1.4

12.77

12.46

u/l

0.38

504

1719

Later onset COPD

236

848

2.21

26.94

1.4

13.17

13.62

u/l

0.51

225

808

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

100

5.42

26.90

1.3

1.2

11.42

15.00

u/l

2.95

Symptoms and signs involving the urinary system

426

1854

1.78

26.63

1.4

12.64

12.86

u/l

0.29

412

1785

Reimbursement for rheumatic diseases

301

1536

1.96

26.58

1.5

1.4

13.38

12.42

u/l

1.26

289

1487

Hypo-osmolality and hyponatraemia

122

422

2.91

26.21

1.4

13.05

12.68

u/l

0.24

116

399

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

240

765

2.18

25.87

1.5

1.4

14.37

13.44

u/l

0.92

227

733

Diabetic nephropathy, excluding more controls

112

304

3.12

25.83

1.4

17.56

13.51

u/l

4.86

101

296

General examination and investigation of persons without complaint and reported diagnosis

337

922

1.95

25.68

1.6

1.4

13.14

12.42

u/l

0.82

317

897

COPD, hospital admissions 1, only main diagnosis

259

1076

2.07

25.50

1.4

12.74

13.30

u/l

0.74

248

1032

Finngen Rheumatological endpoints

478

1578

1.73

25.46

1.5

1.4

12.86

12.26

u/l

0.92

460

1527

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

242

776

2.15

25.30

1.5

1.4

14.45

13.42

u/l

1.07

231

744

Symptoms and signs involving the digestive system and abdomen

522

1549

1.69

24.90

1.5

1.4

13.02

12.52

u/l

0.78

498

1503

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

239

771

2.14

24.86

1.5

1.4

14.44

13.43

u/l

1.03

226

739

Adjustment and management of implanted device

133

500

2.69

24.61

1.4

14.75

13.71

u/l

0.79

124

481

STROKE

298

1060

1.96

24.44

1.5

1.4

13.00

11.81

u/l

2.24

288

1026

Hypertensive diseases

355

1076

1.87

24.38

1.6

1.4

13.25

11.47

u/l

4.36

339

1049

Gout, FINNGEN

213

993

2.16

24.37

1.5

1.4

15.00

12.93

u/l

3.30

202

953

Insulin medication

340

1581

1.85

24.32

1.5

1.4

16.97

12.21

u/l

18.71

316

1529

Other systemic involvement of connective tissue

164

685

2.41

24.32

1.5

13.67

12.81

u/l

0.73

155

658

Hypertension

354

1076

1.87

24.10

1.6

1.4

13.28

11.47

u/l

4.49

338

1049

Senile cataract

362

1225

1.84

24.04

1.4

13.46

12.19

u/l

2.38

339

1182

Other systemic involvement of connective tissue (FG)

153

619

2.47

23.94

1.4

13.71

12.50

u/l

1.09

145

597

Nausea and vomiting

151

601

2.49

23.88

1.7

1.4

14.19

12.88

u/l

1.27

144

579

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

328

1784

1.84

23.79

1.5

1.4

12.93

12.78

u/l

0.15

316

1722

Diagnoses used for exclusion with ILD

172

746

2.32

23.45

1.6

1.4

13.46

12.88

u/l

0.40

167

714

Use of hypnotics and sedatives

535

1892

1.64

23.42

1.4

12.38

12.74

u/l

0.60

514

1832

Acute sinusitis

234

1076

2.04

22.71

1.8

1.4

12.61

12.23

u/l

0.33

228

1037

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

236

3.40

22.62

1.3

1.5

10.13

13.23

u/l

4.02

225

Diseases of liver

194

900

2.17

22.48

1.6

1.4

17.44

12.18

u/l

9.80

186

868

Hypertensive Heart Disease

158

541

2.41

22.41

1.4

14.09

11.98

u/l

4.47

153

524

Constipation

455

1960

1.67

22.24

1.5

1.4

12.82

12.83

u/l

0.01

437

1894

Obesity related asthma

177

796

2.24

22.15

1.6

1.4

12.64

12.59

u/l

0.03

170

771

Endocrine, nutritional and metabolic diseases

369

1043

1.80

22.07

1.5

1.4

12.80

11.44

u/l

3.17

359

1012

Peripheral artery disease

295

1275

1.87

21.85

1.4

15.47

12.94

u/l

5.98

278

1227

Other respiratory diseases principally affecting the interstitium

136

552

2.49

21.59

1.6

1.4

14.43

13.21

u/l

1.03

131

529

Ulcer of lower limb, not elsewhere classified

108

391

2.80

21.58

1.5

1.4

15.87

13.25

u/l

2.47

103

376

ILD, hospital admissions

118

449

2.66

21.43

1.7

1.5

14.25

13.28

u/l

0.68

113

429

Operations 2 for CAVS

215

1037

2.05

21.24

1.5

1.4

15.32

13.19

u/l

3.89

204

992

Calcific aortic valvular stenosis, diagnosis (helper)

215

1037

2.05

21.24

1.5

1.4

15.32

13.19

u/l

3.89

204

992

Abnormal findings on examination of blood, without diagnosis

290

1475

1.85

21.23

1.6

1.4

13.74

12.91

u/l

1.15

274

1421

Persons encountering health services for other counselling and medical advice, not elsewhere classified

530

1890

1.60

21.21

1.5

1.4

13.24

12.59

u/l

1.17

520

1818

Viral infections characterized by skin and mucous membrane lesions

210

1026

2.06

21.21

1.5

13.25

12.58

u/l

0.54

201

991

Calcific aortic valvular stenosis, operated

215

1038

2.04

21.18

1.5

1.4

15.32

13.20

u/l

3.87

204

993

Calcific aortic valvular stenosis

215

1038

2.04

21.18

1.5

1.4

15.32

13.20

u/l

3.87

204

993

Chronic sinusitis

218

1082

2.02

21.09

1.8

1.4

11.72

12.59

u/l

1.12

213

1047

Calcific aortic valvular stenosis, including rheumatic fever

215

1040

2.04

21.02

1.5

1.4

15.32

13.18

u/l

3.91

204

995

Volume depletion

210

3.47

20.81

1.3

1.4

15.93

13.19

u/l

1.22

197

Antihypertensive medication - note that there are other indications

216

560

2.12

20.70

1.6

1.4

12.29

11.05

u/l

1.42

209

547

Other interstitial pulmonary diseases

118

458

2.61

20.61

1.7

1.5

14.25

13.25

u/l

0.71

113

438

Interstitial lung disease endpoints

118

459

2.60

20.52

1.7

1.5

14.25

13.24

u/l

0.73

113

439

Interstitial lung disease

118

459

2.60

20.52

1.7

1.5

14.25

13.24

u/l

0.73

113

439

Pure hypercholesterolaemia

377

1475

1.72

20.46

1.5

1.4

13.79

12.57

u/l

2.18

363

1418

Other soft tissue disorders, not elsewhere classified

446

1674

1.65

20.41

1.5

1.4

12.79

12.63

u/l

0.17

427

1620

Diseases of the digestive system

271

1465

1.86

20.27

1.5

1.4

14.68

12.95

u/l

3.01

259

1413

Injuries to the head

518

2137

1.58

20.25

1.4

13.17

12.56

u/l

1.09

495

2070

Iron deficiency anaemia secondary to blood loss (chronic)

105

390

2.72

19.99

1.4

15.08

13.41

u/l

1.59

371

Cerebrovascular diseases

405

1744

1.67

19.95

1.4

13.52

12.77

u/l

1.44

386

1685

Chronic periodontitis, complicated

213

3.38

19.67

1.4

13.17

12.87

u/l

0.10

206

Unspecified acute lower respiratory infection

328

2.86

19.53

1.7

1.5

12.91

12.84

u/l

0.03

314

Hyperlipidaemia, other/unspecified

235

1164

1.92

19.44

1.6

1.4

13.98

12.79

u/l

2.20

226

1115

Insulin, combination of fast acting with intermediate-acting or long-acting

340

1833

1.72

19.38

1.5

1.4

16.97

12.51

u/l

16.84

316

1776

Gastrointestinal diseases

258

669

1.94

19.13

1.7

1.4

12.65

11.88

u/l

0.89

249

654

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

144

397

2.38

19.02

1.5

1.4

11.51

12.73

u/l

1.62

137

384

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

144

397

2.38

19.02

1.5

1.4

11.51

12.73

u/l

1.62

137

384

Substance abuse, excluding more controls

290

1425

1.79

18.90

1.3

1.4

12.11

12.86

u/l

1.20

281

1376

Pain in limb

376

1627

1.68

18.88

1.5

1.4

12.99

12.61

u/l

0.48

355

1575

Insulin, intermediate and long-acting

303

1702

1.75

18.81

1.5

1.4

17.28

12.48

u/l

16.87

283

1650

Hard cardiovascular diseases

398

1545

1.66

18.76

1.4

1.5

13.85

12.47

u/l

3.11

385

1493

Gout, idiopatic and unspecified

173

829

2.11

18.59

1.5

1.4

14.64

12.95

u/l

2.36

168

797

Cardiodefibrillation

238

1272

1.88

18.59

1.5

1.4

14.51

12.84

u/l

2.47

231

1223

Disorders of choroid and retina

421

1900

1.62

18.48

1.4

14.10

12.74

u/l

3.01

399

1838

Benign neoplasms

478

1686

1.59

18.37

1.5

1.4

12.71

12.58

u/l

0.14

465

1627

Insulin, fast-acting

199

1007

1.99

18.32

1.5

1.4

17.30

12.33

u/l

10.60

184

974

Benign neoplasm of colon, rectum, anus and anal canal

340

1825

1.69

18.21

1.4

13.49

12.88

u/l

0.95

332

1750

Dermatitis

293

1697

1.73

17.57

1.5

1.4

13.65

12.51

u/l

2.02

282

1637

Other and unspecified dermatitis

245

1350

1.82

17.44

1.5

1.4

13.84

12.43

u/l

2.30

235

1307

Persons encountering health services for examination and investigation

321

924

1.75

17.30

1.5

1.4

12.97

12.43

u/l

0.63

307

899

Osteopathies and chondropathies

264

1420

1.77

16.93

1.6

1.4

12.95

12.76

u/l

0.16

255

1368

Symptoms and signs involving cognition, perception, emotional state and behaviour

458

2070

1.55

16.92

1.5

1.4

12.73

12.66

u/l

0.08

437

2008

Other CVD

131

585

2.26

16.85

1.6

1.4

14.60

13.43

u/l

1.11

126

557

Other diseases of the digestive system

198

1035

1.93

16.69

1.5

1.4

15.02

13.12

u/l

2.34

187

992

Atherosclerosis, excluding cerebral and coronary sclerosis

267

1211

1.77

16.66

1.4

15.07

12.99

u/l

4.02

251

1167

Coronary atherosclerosis

357

1399

1.65

16.63

1.5

1.4

14.16

12.33

u/l

5.47

342

1345

Other retinal disorders

342

1669

1.65

16.63

1.4

14.43

12.90

u/l

3.30

321

1612

Drug-induced neutropenia

143

3.69

16.50

1.4

12.23

13.41

u/l

0.29

135

GI-bleeding

200

1053

1.91

16.50

1.5

1.4

15.16

13.17

u/l

2.56

189

1010

Insulin, fast-acting or short human

201

1059

1.91

16.50

1.5

1.4

17.24

12.52

u/l

9.87

186

1023

Convulsions, not elsewhere classified

109

447

2.42

16.48

1.6

1.4

12.93

12.23

u/l

0.54

104

438

Polyneuropathies and other disorders of the peripheral nervous system

141

655

2.17

16.48

1.5

13.68

12.88

u/l

0.56

133

627

Benign neoplasm: Colon, unspecified

117

502

2.33

16.32

1.6

1.4

13.34

13.36

u/l

0.01

111

482

Fall on same level

521

1929

1.51

16.27

1.5

1.4

12.95

12.46

u/l

0.74

496

1875

Diabetic nephropathy

112

470

2.38

16.17

1.4

17.56

14.44

u/l

3.29

101

454

Chronic periodontitis

102

417

2.47

16.07

1.4

13.13

12.55

u/l

0.31

404

Diabetes mellitus

462

1795

1.54

15.89

1.5

1.4

14.54

11.73

u/l

9.71

444

1744

Syncope and collapse

218

1054

1.84

15.76

1.5

1.4

13.50

12.59

u/l

1.19

204

1026

Intracranial trauma

247

1036

1.79

15.76

1.6

1.4

13.25

12.43

u/l

0.89

235

1006

Acute upper respiratory infections

485

2009

1.52

15.70

1.6

1.4

12.72

12.67

u/l

0.05

470

1935

Diabetes, varying definitions

460

1795

1.53

15.62

1.5

1.4

14.56

11.74

u/l

9.67

442

1744

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

193

788

1.92

15.50

1.4

13.12

13.42

u/l

0.24

188

755

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

288

1720

1.68

15.48

1.5

1.4

12.91

12.76

u/l

0.15

277

1659

ILD, hospital admissions 1, main diag only

401

2.47

15.46

1.6

1.4

14.67

13.22

u/l

1.07

382

Mental and behavioural disorders due to psychoactive substance use

298

1695

1.66

15.36

1.3

1.5

12.07

12.86

u/l

1.38

289

1637

Glucagon-like peptide-1 (GLP-1) analogues

307

1528

1.66

15.29

1.5

1.4

16.35

12.45

u/l

10.86

288

1467

Headache

239

1129

1.77

15.23

1.7

1.4

12.25

12.14

u/l

0.09

233

1099

Substance abuse

290

1665

1.67

15.18

1.3

1.5

12.11

12.89

u/l

1.31

281

1607

Viral infections of the central nervous system

120

3.79

14.94

1.5

1.4

12.24

13.33

u/l

0.32

113

Benzodiazepine use

461

2184

1.51

14.83

1.4

12.00

12.84

u/l

1.89

441

2113

Non-small cell lung cancer, squamous

159

3.40

14.83

1.3

1.4

11.42

14.29

u/l

3.04

147

Non-small cell lung cancer, squamous, helper endpoint

159

3.40

14.83

1.3

1.4

11.42

14.29

u/l

3.04

147

Factors influencing health status and contact with health services

147

341

2.17

14.79

1.4

1.3

13.57

11.96

u/l

1.51

138

335

Type 2 diabetes

449

1754

1.52

14.77

1.5

1.4

14.62

11.71

u/l

9.82

431

1703

Childhood asthma (age<16), excluding more controls

6.02

14.75

1.7

1.4

11.82

12.14

u/l

0.07

Sleep disorders (combined)

455

1977

1.51

14.72

1.4

12.70

12.64

u/l

0.07

438

1910

Diseases of the eye and adnexa

352

1088

1.62

14.65

1.5

1.4

12.18

12.06

u/l

0.11

340

1055

Neurological diseases, wide definition

126

275

2.31

14.59

1.5

1.3

12.44

10.92

u/l

1.18

120

266

Respiratory tuberculosis, confirmed

5.56

14.58

1.4

1.3

16.00

14.47

u/l

0.35

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

435

1744

1.53

14.54

1.4

15.31

11.77

u/l

12.54

414

1693

Psychiatric diseases

511

1724

1.49

14.49

1.5

1.4

12.01

12.81

u/l

1.99

496

1667

Disorders of gallbladder, biliary tract and pancreas

469

2024

1.50

14.43

1.5

1.4

13.87

12.43

u/l

4.17

445

1959

Other neurological diseases

370

1916

1.56

14.20

1.5

1.4

13.14

12.91

u/l

0.27

356

1846

Other and unspecified polyneuropathies, also in other diseases

124

583

2.15

14.14

1.5

13.88

12.91

u/l

0.64

118

558

Abdominal and pelvic pain

464

1549

1.51

14.13

1.5

1.4

12.71

12.52

u/l

0.23

447

1503

Childhood asthma (age<16)

5.71

14.05

1.7

1.4

11.82

12.36

u/l

0.12

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

458

2002

1.49

13.97

1.6

1.4

13.58

12.59

u/l

1.92

437

1938

294

1665

1.63

13.85

1.4

13.33

12.74

u/l

0.68

283

1607

Gastroduodenal ulcer

163

850

1.92

13.84

1.5

1.4

14.53

13.09

u/l

1.34

155

820

Neurological diseases

390

1263

1.56

13.73

1.5

12.11

12.54

u/l

0.57

376

1221

Respiratory tuberculosis, bacteriologically and histologically confirmed

5.25

13.72

1.4

1.3

16.00

14.41

u/l

0.38

Peripheral arterial reconstruction

124

592

2.11

13.62

1.3

1.4

16.07

13.15

u/l

2.98

116

569

Other cataract

226

1005

1.75

13.55

1.5

1.4

13.76

12.27

u/l

2.34

219

971

Other anxiety disorders

158

725

1.94

13.51

1.7

1.4

11.43

12.06

u/l

0.60

153

708

Secondary right heart disease

106

3.85

13.47

1.5

1.4

13.70

14.33

u/l

0.21

Malignant neoplasm of skin

339

1636

1.57

13.20

1.5

1.4

14.44

12.91

u/l

2.93

323

1575

Open wound of head

257

1533

1.66

13.19

1.3

1.4

13.67

12.85

u/l

1.06

249

1479

Hernia

425

1935

1.49

13.12

1.4

12.42

12.75

u/l

0.46

415

1863

Other pulmonary heart/vessel disease

118

3.62

13.01

1.5

1.4

13.50

14.85

u/l

0.51

111

Cellulitis

114

537

2.14

12.96

1.8

1.5

13.55

12.77

u/l

0.53

109

517

Mycoses

136

684

2.00

12.96

1.6

1.5

13.80

12.42

u/l

1.34

127

656

Dermatitis and eczema

482

2179

1.45

12.91

1.5

1.4

13.44

12.52

u/l

2.11

467

2103

Alcohol use disorder, Swedish definition

279

1607

1.62

12.90

1.4

13.51

12.75

u/l

0.93

269

1549

300

1697

1.59

12.81

1.4

13.27

12.73

u/l

0.62

289

1638

Other/unspecified cytomegaloviral diseases

7.69

12.75

1.5

1.3

23.67

14.92

u/l

1.07

Stroke, including SAH

335

1598

1.56

12.72

1.4

13.41

12.97

u/l

0.58

320

1542

Ischemic heart diseases

366

1497

1.54

12.69

1.5

1.4

13.88

12.33

u/l

3.60

354

1441

Heart failure and hypertrophic cardiomyopathy

5.65

12.68

1.5

15.46

13.79

u/l

0.46

Type 1 diabetes, wide definition, subgroup 1

100

451

2.23

12.63

1.4

1.5

17.10

12.00

u/l

9.36

438

Benign neoplasm: Colon

279

1713

1.60

12.49

1.5

1.4

13.54

13.01

u/l

0.66

272

1644

Other antidepressants

499

1807

1.44

12.38

1.5

1.4

12.16

12.89

u/l

1.75

477

1750

Diabetes, insulin treatment (Kela reimbursement)

456

1916

1.46

12.33

1.4

15.28

11.91

u/l

12.30

435

1857

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

285

2.51

12.13

1.5

11.83

13.02

u/l

1.03

274

Other and unspecified coagulation defects

4.65

12.13

1.4

13.96

14.63

u/l

0.14

Genitourinary diseases

280

860

1.64

12.12

1.5

1.4

12.80

12.29

u/l

0.54

271

834

Diabetes medication

448

1877

1.45

11.90

1.5

1.4

14.93

11.86

u/l

12.01

430

1819

Noninfective enteritis and colitis

206

1210

1.71

11.90

1.5

1.4

13.63

12.50

u/l

1.29

196

1172

Urticaria and erythema

148

789

1.88

11.89

1.5

11.89

12.43

u/l

0.46

142

762

Other necrotizing vasculopathies

161

3.08

11.86

1.6

1.5

12.82

13.31

u/l

0.19

153

Any mental disorder

509

1790

1.43

11.78

1.5

1.4

11.88

12.91

u/l

3.17

494

1730

Concussion

200

1012

1.71

11.54

1.5

1.4

13.01

12.43

u/l

0.47

190

983

Episodal and paroxysmal disorders

494

1778

1.43

11.50

1.5

1.4

12.51

12.60

u/l

0.10

472

1718

Ischaemic Stroke, excluding all haemorrhages

308

1513

1.54

11.39

1.4

13.62

13.05

u/l

0.81

294

1461

Type 2 diabetes, definitions combined

416

1703

1.46

11.33

1.5

1.4

14.47

11.79

u/l

7.73

400

1652

Ischaemic heart disease, wide definition

357

1493

1.50

11.20

1.5

1.4

13.96

12.31

u/l

3.88

344

1439

Type 2 diabetes, strict (exclude DM1)

417

1715

1.45

11.13

1.5

1.4

14.48

11.80

u/l

7.78

401

1662

Pain (limb, back, neck, head abdominally)

353

1169

1.52

11.12

1.5

1.4

12.77

12.73

u/l

0.03

336

1135

Type 1 diabetes, wide definition

104

502

2.08

11.12

1.4

1.5

16.90

12.00

u/l

9.38

486

Stroke, excluding SAH

318

1555

1.52

11.08

1.4

13.48

13.01

u/l

0.63

304

1501

Arthropathies

400

1384

1.47

11.04

1.5

1.4

12.52

12.28

u/l

0.30

384

1343

Disorders of other endocrine glands

185

1062

1.72

11.01

1.5

1.4

13.22

12.67

u/l

0.45

179

1020

External causes of morbidity and mortality

302

969

1.56

10.96

1.6

1.4

13.10

12.31

u/l

1.02

289

943

Other disorders of teeth and supporting structures

110

546

2.03

10.96

1.5

1.4

14.63

12.43

u/l

1.52

105

527

Defects in the complement system

29.51

10.84

1.8

1.0

11.79

11.60

u/l

—

Sleep apnoea

409

1925

1.44

10.78

1.4

12.72

12.63

u/l

0.10

393

1861

Other malignant neoplasms of skin (=non-melanoma skin cancer)

295

1527

1.53

10.59

1.5

1.4

14.53

12.97

u/l

2.73

282

1471

malignant neoplasm of female genital organs

276

2.44

10.54

1.3

1.4

10.13

12.78

u/l

2.50

262

Other infectious diseases

190

2.77

10.44

1.9

1.4

15.43

13.79

u/l

0.65

180

Other nutritional deficiencies

249

1554

1.57

10.38

1.5

1.4

13.32

12.24

u/l

1.42

244

1506

Symptoms and signs involving the skin and subcutaneous tissue

295

1950

1.51

10.31

1.5

1.4

12.53

12.64

u/l

0.11

284

1887

Major coronary heart disease event

356

1619

1.47

10.30

1.4

14.50

12.65

u/l

4.63

340

1558

Major coronary heart disease event excluding revascularizations

337

1572

1.48

10.26

1.4

14.41

12.66

u/l

4.24

322

1513

Basal cell carcinoma

299

1582

1.51

10.16

1.5

1.4

14.62

12.96

u/l

2.92

285

1524

Presence of other functional implants

282

1306

1.53

10.08

1.5

1.4

13.44

12.64

u/l

1.30

269

1256

Basal cell carcinoma, including avohilmo

303

1591

1.50

10.08

1.5

1.4

14.64

12.98

u/l

2.98

289

1533

Mental and behavioural disorders due to alcohol

244

1521

1.57

10.07

1.3

1.5

12.25

12.90

u/l

0.87

236

1468

Falls/tendency to fall

477

1710

1.40

10.00

1.5

1.4

12.88

12.41

u/l

0.75

455

1663

Unspecified privation

235

2.53

9.99

2.0

1.5

13.27

13.33

u/l

0.02

227

Anxiety (asthma-related co-morbidities)

201

963

1.65

9.96

1.6

1.4

11.18

12.27

u/l

1.67

195

940

Myocardial infarction

263

1223

1.55

9.86

1.4

14.25

12.58

u/l

3.42

254

1172

Diverticular disease of intestine

333

1504

1.47

9.78

1.4

13.21

12.71

u/l

0.59

319

1454

Mental and behavioural disorders due to alcohol, excluding acute intoxication

215

1349

1.60

9.71

1.4

1.5

12.52

12.71

u/l

0.16

208

1308

Gastro-oesophageal reflux disease

293

1740

1.50

9.67

1.4

12.72

12.49

u/l

0.25

278

1683

Gastric ulcer

104

531

1.97

9.64

1.5

1.4

14.43

12.90

u/l

1.16

512

Other external causes of accidental injury

379

1313

1.45

9.64

1.5

1.4

13.04

12.35

u/l

1.12

362

1272

Disorders of eyelid, lacrimal system and orbit

377

2076

1.43

9.62

1.4

12.09

12.91

u/l

2.16

366

1999

Soft tissue disorders

455

1696

1.40

9.52

1.5

1.4

12.30

12.67

u/l

0.52

440

1642

Accidents

378

1313

1.44

9.49

1.5

1.4

13.00

12.35

u/l

1.01

361

1272

Visual disturbances and blindness

222

1415

1.57

9.43

1.5

1.4

12.60

12.82

u/l

0.20

213

1364

Congenital malformations, deformations and chromosomal abnormalities

213

1288

1.59

9.36

1.7

1.4

11.87

12.30

u/l

0.46

208

1249

Hypertrophic cardiomyopathy

3.46

9.35

1.5

1.4

14.63

14.17

u/l

0.12

Fracture of femur

142

736

1.77

9.31

1.3

1.4

13.32

13.56

u/l

0.16

133

704

Disorders of sclera, cornea, iris and ciliary body

228

1471

1.55

9.20

1.5

1.4

12.64

12.66

u/l

0.01

217

1427

Retention of urine

197

1034

1.62

9.15

1.4

13.26

13.18

u/l

0.06

188

993

Malignant melanoma, excluding all cancers (controls excluding all cancers)

333

2.20

9.14

1.4

13.01

12.97

u/l

0.02

318

Anxiety disorders, excluding more controls

315

1425

1.47

9.12

1.5

1.4

11.90

12.69

u/l

1.31

305

1377

Type 1 diabetes

113

605

1.87

9.06

1.4

1.5

16.76

12.03

u/l

8.69

105

586

Other functional intestinal disorders

203

1219

1.59

8.99

1.6

1.4

12.94

12.86

u/l

0.05

192

1177

Diseases of pulp and periapical tissues, including avohilmo

485

1846

1.37

8.98

1.4

1.5

12.43

12.81

u/l

0.59

465

1785

Dental pulpitis 4

485

1848

1.37

8.92

1.4

1.5

12.42

12.81

u/l

0.61

465

1787

Neurotic, stress-related and somatoform disorders

327

1611

1.45

8.85

1.5

1.4

11.81

12.46

u/l

1.05

317

1560

Symptoms and signs involving the nervous and musculoskeletal systems

251

1668

1.51

8.83

1.4

12.20

12.76

u/l

0.80

244

1606

Dental pulpitis 1

484

1849

1.36

8.78

1.4

1.5

12.43

12.81

u/l

0.59

464

1788

Other (not insulin) diabetes medications

414

1799

1.39

8.74

1.4

14.46

11.94

u/l

7.96

399

1741

Fitting and adjustment of other devices

166

934

1.66

8.70

1.5

1.4

14.16

13.45

u/l

0.60

157

899

Injuries to the hip and thigh

229

1369

1.54

8.66

1.5

1.4

13.17

13.13

u/l

0.03

220

1316

Type 2 diabetes, definitions combined, including avohilmo

403

1714

1.39

8.65

1.5

1.4

14.31

11.75

u/l

6.94

388

1661

Combined immunodeficiencies

6.56

8.58

2.4

1.4

15.14

11.91

u/l

0.73

Alcohol use disorder, ICD-based

197

1251

1.58

8.57

1.4

1.5

12.64

12.73

u/l

0.06

191

1211

Coronary revascularization (ANGIO or CABG)

246

1132

1.52

8.54

1.4

14.88

12.65

u/l

5.43

238

1084

Sleep apnoea, including avohilmo

417

1967

1.38

8.50

1.5

1.4

12.70

12.57

u/l

0.15

401

1903

All anxiety disorders

202

1033

1.58

8.47

1.6

1.4

11.17

12.22

u/l

1.63

196

1009

Benign neoplasm: Descending colon

117

3.02

8.31

1.4

1.3

11.54

13.90

u/l

1.59

110

Intestinal stricture

155

937

1.66

8.27

1.5

1.4

13.47

12.88

u/l

0.43

149

898

Diabetic retinopathy, excluding more controls

119

364

1.85

8.25

1.5

1.4

15.98

13.75

u/l

1.67

114

355

Exposure to unspecified factor

397

2246

1.37

8.19

1.5

1.4

13.06

12.58

u/l

0.70

383

2171

Lung transplant status

17.90

8.15

1.5

1.1

12.58

19.57

u/l

—

Lung transplantation

17.90

8.15

1.5

1.1

12.58

19.57

u/l

—

Phlebitis and thrombophlebitis (not including DVT)

107

585

1.84

8.13

1.7

1.4

13.56

12.73

u/l

0.40

564

Anxiety disorders

329

1647

1.42

8.08

1.5

1.4

11.80

12.51

u/l

1.22

319

1595

Tuberculosis of other organs

4.20

8.04

1.2

1.3

14.62

13.83

u/l

0.22

Failure and rejection of transplanted organs and tissues

8.02

1.3

1.2

17.64

14.21

u/l

0.42

Dorsalgia

432

1719

1.36

8.00

1.5

1.4

12.46

12.68

u/l

0.26

417

1666

Recurring oral aphthae

3.46

7.96

1.4

1.3

13.00

13.78

u/l

0.22

Diseases of the musculoskeletal system and connective tissue

226

737

1.54

7.86

1.5

1.4

13.13

12.00

u/l

1.36

215

721

Budesonide

209

2.40

7.72

1.6

1.4

12.40

12.69

u/l

0.10

204

Volvulus

4.38

7.70

1.4

13.26

13.28

u/l

0.00

Hepatic failure, not elsewhere classified

3.47

7.69

1.8

1.4

21.15

13.77

u/l

1.30

Injuries to the thorax

210

1389

1.52

7.65

1.5

1.4

12.82

12.86

u/l

0.03

204

1337

Other symptoms and signs involving cognitive functions and awareness

221

1385

1.50

7.62

1.4

13.36

13.09

u/l

0.23

211

1341

Intestinal malabsorption

3.62

7.58

2.0

1.3

13.96

13.52

u/l

0.10

Tuberculosis of other organs, strict

3.86

7.56

1.2

1.3

14.41

14.10

u/l

0.08

Asthma mixed form (mode), excluding more controls

5.62

7.54

1.3

1.2

13.79

13.36

u/l

0.08

Sequelae of cerebrovascular disease

191

1088

1.55

7.49

1.4

14.27

13.30

u/l

1.13

182

1050

Covid-19 suspected case

355

2.04

7.45

1.6

1.5

12.74

12.28

u/l

0.25

344

Thyrotoxicosis with toxic multinodular goitre

120

2.86

7.38

1.6

1.5

11.68

13.60

u/l

1.07

111

Other joint disorders

359

1382

1.39

7.38

1.5

1.4

12.22

12.28

u/l

0.06

346

1341

Cerebral palsy and other paralytic syndromes

247

2.24

7.24

1.5

12.09

13.61

u/l

1.05

238

Hepatomegaly and splenomegaly, not elsewhere classified

7.89

7.15

1.0

1.9

17.20

11.00

u/l

—

Type of accident

117

684

1.72

7.14

1.7

1.5

14.51

12.50

u/l

1.62

108

659

Unspecified fall

208

1385

1.49

7.10

1.6

1.4

12.78

12.96

u/l

0.17

198

1340

Degeneration of macula and posterior pole

239

1354

1.46

7.08

1.4

13.53

13.08

u/l

0.55

225

1305

Supplementary factors related to causes of morbidity and mortality classified elsewhere

125

746

1.68

7.07

1.7

1.5

14.43

12.54

u/l

1.58

115

720

Other skin changes

448

1.89

6.98

1.5

13.14

13.09

u/l

0.02

429

Infections with a predominantly sexual mode of transmission

505

1.83

6.94

1.6

1.5

12.43

11.75

u/l

0.44

492

Unspecified haematuria

211

1219

1.49

6.92

1.4

13.34

13.08

u/l

0.25

204

1168

Small cell lung cancer, helper endpoint

3.39

6.86

1.2

1.5

11.25

14.22

u/l

1.92

Small cell lung cancer

3.39

6.86

1.2

1.5

11.25

14.22

u/l

1.92

118

661

1.70

6.86

1.4

1.5

13.91

13.43

u/l

0.37

113

630

Dizziness and giddiness

319

1883

1.38

6.84

1.5

1.4

12.87

12.80

u/l

0.08

302

1825

Injury, poisoning and certain other consequences of external causes

233

791

1.48

6.76

1.6

1.4

13.18

12.35

u/l

0.93

223

769

Spondylopathies

357

1599

1.36

6.71

1.5

1.4

12.42

12.82

u/l

0.59

339

1548

Intracranial injury

243

1644

1.43

6.67

1.5

1.4

13.45

12.84

u/l

0.61

230

1590

Malignant neoplasm of breast

157

718

1.58

6.65

1.5

1.4

11.63

12.66

u/l

1.43

150

692

Biguanides

401

1859

1.33

6.62

1.4

14.40

12.19

u/l

6.14

387

1795

Cholelithiasis, broad definition with cholecystitis

375

1920

1.34

6.61

1.4

14.19

12.44

u/l

4.87

357

1857

Injuries to the abdomen, lower back, lumbar spine and pelvis

169

1097

1.53

6.59

1.4

1.5

13.98

12.81

u/l

1.27

163

1051

Exposure to other specified factors

277

1864

1.40

6.58

1.6

1.4

12.61

12.58

u/l

0.03

272

1803

Chronic gastritis

133

823

1.62

6.57

1.6

1.4

13.65

13.10

u/l

0.36

128

793

Pain in joint

230

1048

1.46

6.53

1.5

1.4

12.40

12.54

u/l

0.11

222

1015

Mental and behavioural disorders due to tobacco

164

2.46

6.51

1.3

1.5

10.85

13.03

u/l

1.64

158

Aspergillosis

6.33

6.48

1.5

1.6

11.09

16.33

u/l

1.40

Visual disturbances

191

1286

1.49

6.48

1.5

1.4

12.53

12.84

u/l

0.26

184

1242

Smoking dependency

165

2.44

6.43

1.3

1.5

10.85

13.04

u/l

1.66

158

Myocardial infarction, strict

232

1176

1.44

6.41

1.4

14.39

12.57

u/l

3.72

226

1127

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

274

2.09

6.38

1.4

12.92

13.23

u/l

0.10

264

Coronary artery bypass grafting

164

811

1.55

6.35

1.4

14.94

12.90

u/l

3.75

158

778

Left bundle-branch block

119

2.71

6.34

1.2

1.4

13.38

11.83

u/l

0.78

112

Fracture of lumbar spine and pelvis

103

602

1.72

6.32

1.4

14.86

13.13

u/l

1.48

573

Other diseases of upper respiratory tract

481

1941

1.29

6.31

1.5

1.4

12.36

12.93

u/l

0.96

468

1873

Pyogenic arthritis

150

2.49

6.19

1.4

1.5

12.24

13.45

u/l

0.52

143

Recurring oral aphthae, including avohilmo

278

2.06

6.16

1.5

13.00

13.18

u/l

0.08

267

Parodontitis

371

2067

1.33

6.15

1.4

12.40

12.70

u/l

0.38

360

1995

Benign neoplasm: Transverse colon

181

2.34

6.15

1.5

1.4

12.69

13.32

u/l

0.22

173

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

204

1377

1.45

6.14

1.6

1.4

11.47

12.62

u/l

2.44

198

1335

Malignant neoplasm of breast, HER2-negative

152

718

1.56

6.12

1.4

11.68

12.64

u/l

1.26

145

692

Carcinoma in situ of skin of other and unspecified parts of face

151

2.47

6.11

1.5

1.3

13.65

14.59

u/l

0.37

143

Parodontitis or operation codes

371

2068

1.32

6.10

1.4

12.40

12.69

u/l

0.37

360

1996

Duodenal ulcer

336

1.95

6.00

1.5

1.4

14.82

13.32

u/l

0.65

322

Allergic urticaria

123

2.62

5.96

2.2

1.4

13.13

12.94

u/l

0.05

117

Other diseases of stomach and duodenum

141

2.50

5.94

1.5

15.60

13.44

u/l

0.78

135

Benign neoplasm of eye and adnexa

147

2.46

5.93

1.3

1.4

12.11

13.47

u/l

0.77

140

Emergency coronary revascularization (for ACS)

287

1511

1.37

5.86

1.4

14.69

13.03

u/l

3.91

278

1446

Transient ischemic attack

251

1497

1.39

5.85

1.4

13.70

13.00

u/l

0.96

240

1449

Hypothyroidism, strict autoimmune

280

1350

1.38

5.85

1.5

1.4

13.37

12.28

u/l

1.71

272

1311

Chronic periodontitis, including avohilmo

367

2068

1.32

5.80

1.4

12.42

12.69

u/l

0.34

356

1996

Diabetic retinopathy

161

667

1.53

5.80

1.5

1.4

16.28

14.54

u/l

1.53

150

641

Other diseases of liver

397

1.85

5.78

1.3

1.5

15.54

12.19

u/l

2.95

383

Unspecified misadventure during surgical and medical care

108

2.71

5.76

1.7

1.3

12.31

13.51

u/l

0.35

102

Asthma mixed form (mode)

4.39

5.76

1.3

1.5

13.79

13.47

u/l

0.07

Other specific joint derangements/joint disorders

268

1306

1.38

5.69

1.6

1.4

12.21

12.17

u/l

0.04

260

1267

Nerve, nerve root and plexus disorders

442

2167

1.28

5.68

1.5

1.4

13.26

12.58

u/l

1.12

417

2102

Hypersplenism

13.59

5.66

2.2

2.0

24.00

10.86

u/l

—

157

925

1.51

5.64

1.3

1.4

13.85

13.27

u/l

0.59

149

881

Disorders of skin appendages

168

1136

1.48

5.63

1.7

1.4

11.80

12.38

u/l

0.59

161

1101

Keratitis

137

890

1.54

5.57

1.4

1.5

12.63

u/l

0.00

128

855

Dental operations

318

1215

1.35

5.54

1.5

1.4

12.69

13.19

u/l

0.63

304

1171

Angina pectoris

269

1329

1.37

5.52

1.5

1.4

14.12

12.47

u/l

3.41

255

1276

Post-traumatic stress disorder

3.07

5.49

2.8

1.4

12.64

14.08

u/l

0.36

Other condition

271

2.00

5.44

1.6

1.5

14.81

12.87

u/l

0.71

265

Secondary thrombocytopenia

5.67

5.34

1.0

1.2

12.00

16.44

u/l

—

Spondyloarthritis

437

1.77

5.33

1.4

12.04

12.85

u/l

0.68

417

Sub-endpoint used in defining T1D endpoints

125

791

1.56

5.32

1.4

1.5

16.90

12.70

u/l

7.73

112

766

Diseases of oral cavity, salivary glands and jaws

392

1554

1.30

5.27

1.5

1.4

12.92

12.78

u/l

0.14

375

1497

Gingivitis and periodontal diseases

384

1529

1.30

5.25

1.4

12.61

12.72

u/l

0.11

373

1473

Crohn's disease of small intestine

103

2.64

5.14

1.6

1.3

12.00

13.69

u/l

0.47

Congenital malformations of cardiac septa

2.81

5.12

1.6

1.4

13.54

14.31

u/l

0.14

Cholelithiasis

351

1898

1.30

5.09

1.4

14.16

12.45

u/l

4.42

335

1836

Clear cell adenocarcinoma of kidney

116

2.53

5.05

1.2

1.4

11.52

13.93

u/l

0.71

110

Demyelinating diseases of the central nervous system

116

2.51

5.03

1.3

1.8

9.76

13.23

u/l

2.71

111

Disorders of adult personality and behaviour

513

1.68

5.01

1.7

1.4

10.87

11.80

u/l

0.76

499

Other diseases of urinary system

430

1910

1.27

5.00

1.5

1.4

13.21

12.50

u/l

1.35

413

1848

Spirochaetal infections, other/unspecified

179

2.19

5.00

1.5

11.67

13.59

u/l

0.76

171

Diaphragmatic hernia

155

1062

1.46

4.94

1.5

1.4

12.54

12.95

u/l

0.37

148

1020

Follow-up examination after treatment for conditions other than malignant neoplasms

158

703

1.47

4.92

1.7

1.4

13.71

12.19

u/l

1.24

152

683

Low back pain

286

1665

1.32

4.88

1.4

12.82

12.64

u/l

0.16

274

1614

Intestinal adhesions without obstruction

188

2.14

4.84

1.5

12.50

13.20

u/l

0.22

178

Superficial injury of head

526

1.66

4.83

1.3

1.5

14.09

12.61

u/l

0.96

508

Follicular lymphoma, hilmo

102

2.58

4.73

1.6

1.4

14.27

13.87

u/l

0.09

Other disorders of ear

379

1986

1.27

4.71

1.5

1.4

12.66

12.72

u/l

0.07

361

1922

Dental caries 3 and operation codes

394

1590

1.27

4.68

1.6

1.4

12.65

12.89

u/l

0.29

381

1532

Septal defects

2.87

4.67

1.5

1.4

13.29

13.58

u/l

0.04

Acute pharyngitis

191

2.09

4.57

1.6

1.4

11.53

12.44

u/l

0.37

186

Mood disorders, excluding more controls

353

1683

1.28

4.48

1.4

12.20

12.79

u/l

0.96

344

1626

Fracture of shoulder and upper arm

142

976

1.46

4.48

1.4

12.95

12.99

u/l

0.02

135

939

Other specified and unspecified disorders of eye and adnexa

2.95

4.45

1.6

1.4

10.05

13.95

u/l

1.88

Specific personality disorders

402

1.72

4.43

1.9

1.4

11.22

11.95

u/l

0.44

392

Exclusions for E4_PCOS_CONSORTIUM

212

971

1.37

4.42

1.4

1.5

11.97

12.29

u/l

0.26

204

940

Disorders of calcium metabolism

124

2.36

4.41

1.3

1.4

17.93

13.09

u/l

1.04

117

Benign neoplasm: Colon, unspecified

117

778

1.51

4.39

1.6

1.4

13.34

12.88

u/l

0.31

111

746

Respiratory disorders in diseases classified elsewhere

4.31

4.38

1.6

1.4

16.45

13.92

u/l

0.38

Benign neoplasm: Descending colon

163

2.16

4.37

1.4

11.54

13.72

u/l

1.40

154

Parodontitis and operation codes

336

2051

1.28

4.37

1.4

12.56

12.64

u/l

0.08

326

1979

Other symptoms and signs involving the nervous and musculoskeletal systems

157

1106

1.42

4.36

1.3

1.5

11.58

12.70

u/l

1.66

152

1068

Dental caries 3

361

1450

1.27

4.36

1.6

1.4

12.73

12.89

u/l

0.17

350

1396

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

9.38

4.34

1.4

1.8

14.75

11.67

u/l

—

Disorders of eyelid in diseases classified elsewhere

3.23

4.34

1.4

1.5

10.44

15.11

u/l

1.71

Conductive and sensorineural hearing loss

340

1851

1.27

4.32

1.4

13.02

12.87

u/l

0.17

323

1789

Dental pulpitis 4, only avohilmo

460

1944

1.24

4.32

1.4

1.5

12.58

12.79

u/l

0.27

443

1876

Infectious mononucleosis

2.66

4.31

1.9

1.5

13.14

12.47

u/l

0.16

Inflammatory bowel disease

116

774

1.50

4.28

1.6

1.5

13.11

12.46

u/l

0.41

110

749

Papulosquamous disorders

151

1061

1.43

4.27

1.4

1.5

14.03

12.48

u/l

1.72

143

1025

Depression

342

1855

1.27

4.27

1.4

12.01

12.54

u/l

0.82

335

1791

Amyloidosis

3.19

4.23

1.2

1.4

12.87

13.78

u/l

0.17

Postprocedural disorders of nervous system

2.63

4.22

1.5

10.91

12.77

u/l

0.75

Alcohol dependence

120

809

1.49

4.22

1.4

1.5

12.50

12.68

u/l

0.09

115

782

Dental caries 1 and operation codes

381

1553

1.26

4.21

1.6

1.4

12.64

12.94

u/l

0.38

369

1496

Benign leiomyoma with endometriosis

199

2.02

4.21

1.4

1.5

12.85

13.28

u/l

0.17

191

Psoriasis

110

729

1.51

4.20

1.4

1.5

14.33

12.41

u/l

1.63

103

704

Biological medicines for asthma

7.03

4.18

1.6

1.2

9.67

14.46

u/l

—

Benign neoplasm: Caecum

187

2.04

4.13

1.5

1.4

14.97

13.23

u/l

0.87

179

Carcinoma in situ of skin of trunk

3.11

4.09

1.7

1.2

14.62

15.49

u/l

0.15

Sulfonylureas

194

1139

1.36

4.09

1.4

17.27

12.67

u/l

8.36

180

1094

Extreme obesity with alveolar hypoventilation

2.65

4.07

1.4

12.24

13.35

u/l

0.39

Thyroiditis, ILD-related definition

175

2.06

4.04

2.1

1.4

12.69

12.66

u/l

0.01

166

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

135

566

1.46

4.02

1.4

12.21

13.55

u/l

1.75

129

543

Coxarthrosis [arthrosis of hip](FG)

233

1275

1.32

4.01

1.5

1.4

13.22

12.58

u/l

0.78

226

1228

Dental caries 1

347

1403

1.27

4.01

1.5

1.4

12.80

12.89

u/l

0.08

336

1350

196

1368

1.35

4.00

1.3

1.4

14.30

13.28

u/l

1.07

184

1311

Corneal ulcer

392

1.69

4.00

1.4

1.6

11.92

12.88

u/l

0.65

379

Shoulder lesions

320

1544

1.27

3.95

1.4

12.48

12.73

u/l

0.27

304

1493

Sensorineural hearing loss

327

1814

1.26

3.94

1.4

13.20

12.88

u/l

0.39

310

1752

Small fibre neuropathy

2.92

3.91

1.6

1.5

15.29

12.68

u/l

0.51

Dental caries, including avohilmo

346

1404

1.26

3.90

1.5

1.4

12.76

12.89

u/l

0.13

335

1350

Dental pulpitis 1, only avohilmo

456

1950

1.22

3.88

1.4

1.5

12.55

12.79

u/l

0.32

439

1882

Diseases of male genital organs

250

964

1.31

3.85

1.5

1.4

12.87

12.98

u/l

0.09

240

934

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

134

557

1.45

3.82

1.4

12.23

13.53

u/l

1.66

128

534

Unspecified chronic bronchitis

2.55

3.80

1.8

1.5

12.19

14.86

u/l

1.60

Other hearing loss

133

919

1.43

3.80

1.5

1.4

14.29

13.20

u/l

1.13

125

882

Other dorsopathies, not elsewhere classified

402

1722

1.23

3.74

1.5

1.4

12.41

12.71

u/l

0.35

389

1669

Coxarthrosis

219

1125

1.32

3.74

1.5

1.4

13.25

12.57

u/l

0.82

212

1087

Benign neoplasm: Parotid gland

128

2.20

3.70

1.9

1.3

13.07

13.53

u/l

0.09

121

Disorders of the thyroid gland

377

1998

1.23

3.69

1.5

1.4

12.89

12.75

u/l

0.15

366

1925

Torsion of ovary, ovarian pedicle and fallopian tube

5.67

3.66

1.6

1.3

10.22

12.25

u/l

—

Statin medication

253

1095

1.30

3.65

1.5

12.86

12.05

u/l

1.24

243

1060

Hyperplasia of prostate

199

849

1.34

3.62

1.5

1.4

12.74

13.06

u/l

0.28

186

820

Maze procedure for atrial fibrillation

8.08

3.59

1.0

1.8

14.00

12.44

u/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

357

1906

1.24

3.59

1.5

1.4

12.94

12.65

u/l

0.33

345

1842

Inguinal hernia

262

1379

1.28

3.59

1.4

12.70

13.03

u/l

0.34

256

1328

Focal brain injury

143

2.11

3.58

1.6

12.83

13.16

u/l

0.12

138

DVT of lower extremities

546

1.54

3.58

1.4

13.66

12.99

u/l

0.24

522

Polycystic ovarian syndrome, consortium definition

186

833

1.35

3.57

1.6

1.4

12.41

11.94

u/l

0.35

178

807

Cyst of kidney

171

2.00

3.54

2.3

1.4

13.62

13.71

u/l

0.03

163

Pollen allergy

246

1.81

3.52

1.4

1.5

10.27

12.39

u/l

1.52

240

Meningitis, viral

10.32

3.52

1.3

1.2

10.17

14.83

u/l

—

Cardiomyopathy in other diseases

10.29

3.52

1.2

2.0

16.00

11.00

u/l

—

Unspecified urinary incontinence

158

2.03

3.50

1.5

14.88

13.52

u/l

0.42

149

Unspecified jaundice

112

2.25

3.48

1.2

1.4

15.88

13.76

u/l

0.63

104

Focal epilepsy, mode (most common among epilepsy diagnosis)

456

1.58

3.44

1.5

12.96

12.91

u/l

0.02

437

Hypothyroidism, other/unspecified

344

1840

1.24

3.43

1.5

1.4

12.98

12.70

u/l

0.32

332

1776

Dorsopathies

411

1724

1.22

3.42

1.5

1.4

12.42

12.71

u/l

0.34

395

1671

Mood disorders

372

1998

1.22

3.40

1.4

12.13

12.60

u/l

0.72

363

1929

Neuromuscular dysfunction of bladder

223

1.85

3.40

1.3

1.5

11.81

13.34

u/l

0.79

212

Amyloidosis, other/unspecified

3.14

3.39

1.2

1.3

13.31

13.43

u/l

0.02

Mood [affective] disorders

370

1993

1.22

3.35

1.5

1.4

12.13

12.59

u/l

0.72

361

1924

Acute pancreatitis

547

1.52

3.34

1.4

13.10

12.62

u/l

0.25

528

Benign neoplasm of major salivary glands

161

2.00

3.34

2.0

1.4

12.88

13.38

u/l

0.12

154

Other diseases of spinal cord

2.74

3.33

2.9

1.4

10.38

14.35

u/l

1.68

Myocardial infarction, without ST-elevation

197

1391

1.31

3.32

1.4

14.43

13.19

u/l

1.64

190

1337

Use of anticholinesterases

1031

0.67

3.32

1.2

1.4

14.08

13.61

u/l

0.27

984

N06DA Anticholinesterases

1031

0.67

3.32

1.2

1.4

14.08

13.61

u/l

0.27

984

Heterophoria

121

2.16

3.31

1.5

1.4

11.69

13.22

u/l

0.63

116

Speech disturbances, not elsewhere classified

218

1.84

3.31

1.5

1.4

12.12

13.68

u/l

0.85

205

Diabetic retinopathy, strict definition

446

1.54

3.27

1.5

1.4

18.07

14.22

u/l

3.29

432

Lower back pain or/and sciatica

391

2246

1.21

3.21

1.5

1.4

12.91

12.60

u/l

0.37

375

2172

Other and unspecified diseases of blood and blood-forming organs

2.89

3.20

1.7

1.4

11.14

14.20

u/l

0.90

Other disorders of urethra and urinary system

269

1609

1.25

3.17

1.5

1.4

13.52

12.55

u/l

1.26

254

1553

Other diseases of anus and rectum

118

842

1.40

3.16

1.6

1.4

13.17

12.92

u/l

0.11

109

809

Diseases of the ear and mastoid process

453

1919

1.20

3.15

1.5

1.4

12.42

12.52

u/l

0.10

432

1860

Other/unspecified dorsalgia

141

1034

1.36

3.12

1.6

1.4

12.31

12.79

u/l

0.37

135

1003

Anorexia

4.55

3.12

1.2

12.44

14.45

u/l

—

Skin changes due to chronic exposure to nonionizing radiation

182

1317

1.31

3.12

1.3

1.4

14.17

13.29

u/l

0.88

171

1261

Habit and impulse disorders

5.05

3.06

1.4

1.7

12.13

16.69

u/l

—

Actinic keratosis

178

1293

1.31

3.06

1.3

1.4

14.18

13.27

u/l

0.90

168

1238

Disorders of mineral metabolism

167

1.93

3.04

1.5

1.4

17.78

12.91

u/l

1.23

160

Carcinoma in situ of skin of scalp and neck

2.92

3.03

1.5

1.2

14.31

15.62

u/l

0.26

Dental operations, only avohilmo

321

1337

1.23

3.03

1.5

1.4

12.58

13.19

u/l

0.92

308

1285

Colitis, primary sclerosing

5.90

3.03

2.3

1.8

19.71

14.75

u/l

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

10.39

3.01

2.4

1.4

16.60

15.20

u/l

—

Other and unspecified nonscarring hair loss

10.17

2.99

1.4

1.0

11.60

12.20

u/l

—

Depression or dysthymia

280

1260

1.24

2.98

1.5

1.4

12.49

12.75

u/l

0.28

272

1216

Dental caries 3, only avohilmo

360

1518

1.21

2.97

1.6

1.4

12.64

12.96

u/l

0.41

348

1461

Focal epilepsy

538

1.49

2.97

1.5

12.94

12.78

u/l

0.08

517

Sexual dysfunction

4.76

2.93

1.6

1.4

11.50

15.35

u/l

—

Leiomyoma of uterus

367

1.46

2.92

1.3

1.4

12.19

12.38

u/l

0.07

356

Encephalopathy

4.17

2.90

1.2

1.6

20.89

13.86

u/l

—

Dental pulpitis 2

305

1270

1.23

2.90

1.5

1.4

12.91

12.98

u/l

0.06

295

1224

Sequelae of other external causes

102

2.17

2.87

2.4

1.3

15.32

13.31

u/l

0.47

Etanercept

2.30

2.84

1.3

1.4

13.32

13.97

u/l

0.09

Ulcerative colitis, NAS

275

1.68

2.83

1.6

13.39

12.91

u/l

0.17

265

Cluster headache, wide,, including avohilmo

2.41

2.80

1.6

1.4

10.06

13.70

u/l

1.52

Presence of other devices

101

719

1.41

2.80

1.4

15.71

12.97

u/l

2.46

691

Injuries to the shoulder and upper arm

316

2189

1.21

2.78

1.5

1.4

12.57

12.79

u/l

0.24

305

2113

Other interventions on the root canals of the tooth

3.95

2.78

1.7

1.2

12.00

14.39

u/l

—

Cardiac murmurs and other cardiac sounds

122

2.03

2.78

1.6

1.5

15.76

13.40

u/l

0.80

117

Spinal stenosis

225

1405

1.26

2.77

1.4

12.87

13.01

u/l

0.13

212

1356

Other and unspecified myoneural disorders

8.59

2.77

1.8

1.2

14.20

13.67

u/l

—

L02BB Anti-androgens

383

0.47

2.77

1.2

1.4

12.83

13.35

u/l

0.18

367

Implicit parasitic Sepsis

8.54

2.77

1.6

2.2

15.00

11.00

u/l

—

Acute pancreatitis (for exclusion)

573

1.45

2.74

1.4

1.5

13.10

12.84

u/l

0.13

549

Dental caries 1, only avohilmo

347

1472

1.21

2.73

1.4

12.78

12.96

u/l

0.18

337

1415

Coronary angioplasty

174

1033

1.30

2.73

1.4

14.46

12.77

u/l

2.63

167

989

Thyroiditis

111

2.08

2.72

2.4

1.5

14.09

13.03

u/l

0.24

106

Listeriosis

6.19

2.72

1.2

1.9

18.33

13.30

u/l

—

Ulcer of oesophagus, drug-induced

6.17

2.72

1.7

1.9

13.17

12.80

u/l

—

Menorrhagia

102

398

1.42

2.72

1.4

12.86

12.07

u/l

0.46

382

Carcinoma in situ of skin of upper limb, including shoulder

2.62

2.71

1.4

1.3

14.86

13.63

u/l

0.23

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

6.10

2.71

1.2

1.1

12.00

15.40

u/l

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

6.09

2.71

1.3

1.1

11.83

17.20

u/l

—

Benign neoplasm: Short bones of lower limb

6.08

2.71

1.5

1.1

8.00

17.10

u/l

—

Conotruncal defects

6.06

2.70

1.8

1.2

11.17

15.10

u/l

—

Conjunctivitis

229

1602

1.25

2.68

1.6

1.4

11.60

12.36

u/l

1.02

223

1548

Human immunodeficiency virus [HIV] disease resulting in other conditions

4.25

2.68

1.0

1.4

15.12

14.47

u/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.80

2.65

1.4

1.7

18.92

12.63

u/l

1.41

Migraine without aura and triptan purchases

205

1.76

2.64

2.3

1.4

11.42

11.51

u/l

0.03

199

Gonarthrosis [arthrosis of knee](FG)

289

1395

1.22

2.63

1.5

1.4

13.14

12.44

u/l

0.90

281

1346

Focal epilepsy, strict definition

496

1.48

2.62

1.4

1.5

13.15

12.90

u/l

0.12

475

Other specified and unspecified personality disorders

141

1.92

2.60

1.5

12.30

13.00

u/l

0.17

135

Retinal vascular disorders

361

1.56

2.58

1.4

12.72

13.05

u/l

0.14

344

Malignant melanoma

425

1.51

2.58

1.4

13.59

13.14

u/l

0.18

407

Other and unspecified disorders of orbit

7.31

2.56

1.2

1.1

12.60

17.43

u/l

—

Toxoplasmosis

7.29

2.56

1.2

1.3

12.60

14.57

u/l

—

Colitis, primary sclerosing, strict definition

7.22

2.55

2.0

16.80

14.57

u/l

—

Injuries to the ankle and foot

211

1540

1.25

2.55

1.7

1.4

12.35

12.33

u/l

0.01

200

1499

Childhood allergy (age < 16)

2.00

2.51

1.7

1.4

12.13

11.83

u/l

0.06

Sequelae of injuries, of poisoning and of other consequences of external causes

559

1.43

2.50

1.8

1.4

12.57

12.34

u/l

0.11

542

Other diseases of pancreas

172

1.81

2.50

1.5

1.4

14.84

13.27

u/l

0.58

165

Dental pulpitis 2, only avohilmo

308

1307

1.21

2.48

1.5

1.4

12.83

12.96

u/l

0.11

298

1258

Arthrosis

278

1259

1.22

2.43

1.6

1.4

12.44

12.37

u/l

0.06

271

1219

Abnormality of white blood cells, not elsewhere classified

5.08

2.41

1.5

1.1

12.17

15.25

u/l

—

Folate deficiency anaemia

5.08

2.41

1.0

1.3

19.33

17.25

u/l

—

Herpesviral keratitis and keratoconjunctivitis

2.18

2.41

1.3

1.4

16.17

14.18

u/l

0.36

Acute myeloid leukaemia, helper endpoint

5.07

2.41

1.2

1.1

13.17

15.83

u/l

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

5.07

2.41

1.2

1.1

13.17

15.83

u/l

—

Melanoma in situ of upper limb, including shoulder

6.36

2.38

1.0

1.1

19.60

17.25

u/l

—

Speech therapy

717

1.37

2.37

1.9

1.4

13.89

12.47

u/l

0.88

688

Tic disorders

6.30

2.37

1.2

1.0

8.60

18.38

u/l

—

Nail disorders

146

1.86

2.37

1.4

11.52

13.38

u/l

0.75

139

Human immunodeficiency virus [HIV] disease

3.67

2.37

1.0

1.6

15.13

14.55

u/l

—

Other disorders of central nervous system

4.17

2.37

1.6

8.86

13.76

u/l

—

Idiopathic urticaria

3.66

2.37

1.5

1.1

9.50

16.55

u/l

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

3.65

2.36

1.3

1.5

13.75

14.95

u/l

—

Benign neoplasm of ovary

213

1.69

2.35

1.3

1.5

15.44

12.75

u/l

0.71

204

Disorders of conjunctiva

264

1831

1.21

2.33

1.6

1.4

11.60

12.50

u/l

1.54

257

1769

Cystitis

324

1667

1.19

2.31

1.5

1.4

13.03

12.50

u/l

0.73

315

1611

Nonsuppurative otitis media

347

1.50

2.31

1.5

11.20

12.82

u/l

1.78

335

Other enthesopathies

100

738

1.36

2.30

1.5

1.4

13.12

12.29

u/l

0.60

716

Simple and mucopurulent chronic bronchitis

112

1.98

2.30

2.1

1.4

12.73

14.63

u/l

0.58

106

Unspecified protein-energy malnutrition

4.73

2.29

1.2

1.6

11.33

13.15

u/l

—

Thiamine deficiency

4.73

2.29

1.3

1.8

14.83

14.54

u/l

—

Crystal arthropathies, rheuma endpoint

2.71

2.28

1.3

13.27

12.56

u/l

0.18

Viral infections of central nervous system, not elsewhere classified/unspecified

4.66

2.28

1.5

1.7

10.17

16.00

u/l

—

Acute epiglottitis

3.51

2.27

1.6

1.5

13.38

14.22

u/l

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

4.65

2.27

1.3

1.8

21.50

13.54

u/l

—

Other diseases of blood and blood-forming organs

141

1.85

2.27

1.6

1.4

12.58

13.51

u/l

0.31

134

Other and unspecified rosacea

163

1.79

2.26

1.6

1.4

11.31

13.62

u/l

1.06

155

Retinal vascular occlusion

357

1.52

2.26

1.4

12.80

13.07

u/l

0.12

340

Unspecified/other endometriosis

127

1.89

2.25

1.8

1.4

11.58

11.03

u/l

0.15

122

Disorders of plasma-protein metabolism, not elsewhere classified

5.64

2.22

2.0

13.80

15.22

u/l

—

Tic and related disorders

5.60

2.22

1.2

1.0

8.60

17.44

u/l

—

Social phobias

2.20

1.1

1.5

12.38

13.52

u/l

0.24

Melanocytic naevi of upper limb, including shoulder

2.80

2.20

1.5

1.3

15.80

14.29

u/l

—

Ethmoidectomy

264

1.60

2.20

1.5

12.67

12.48

u/l

0.04

254

Sciatica+with lumbago

176

1340

1.25

2.18

1.6

1.4

12.55

u/l

0.00

169

1300

Other strabismus

408

1.47

2.17

1.4

1.5

11.40

12.38

u/l

0.78

395

Cachexia

4.39

2.17

1.8

1.7

9.67

12.21

u/l

—

Other specified/unspecified bacterial intestinal infections

129

1.87

2.17

1.9

1.3

13.13

13.73

u/l

0.18

122

Superficial injury of ankle and foot

188

1.71

2.16

2.6

1.5

10.91

13.18

u/l

1.71

181

Diabetic neuropathy

335

1.52

2.16

1.4

1.5

17.27

14.28

u/l

1.21

322

Diseases of external ear

120

920

1.31

2.16

1.3

1.5

13.04

12.54

u/l

0.33

113

886

Conduct disorder

4.31

2.15

1.0

1.7

10.33

13.14

u/l

—

Benign neoplasm: Skin of trunk

2.17

2.15

1.7

1.4

14.69

13.35

u/l

0.22

Benign neoplasm of bone and articular cartilage

144

1.81

2.14

1.6

1.5

11.50

13.40

u/l

0.80

137

Other diseases of biliary tract

197

1.68

2.12

1.5

14.85

13.67

u/l

0.43

187

Acute bronchiolitis

2.39

2.12

1.8

1.4

11.31

12.78

u/l

0.49

Gonarthrosis

254

1211

1.20

2.10

1.5

1.4

13.01

12.41

u/l

0.66

247

1172

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

3.21

2.09

1.1

1.4

13.88

15.44

u/l

—

Other extrapyramidal and movement disorders in other diseases

606

1.37

2.08

1.4

1.5

11.90

12.80

u/l

0.69

579

Other specified congenital malformation syndromes affecting multiple systems

5.03

2.07

1.0

1.1

14.60

14.70

u/l

—

L02BX Other hormone antagonists and related agents

209

0.43

2.07

1.9

1.5

10.33

13.32

u/l

—

200

Abnormal findings in nipple discharge synovial fluid wound secretions

3.53

2.06

1.1

1.5

11.57

14.15

u/l

—

Benign neoplasm: Short bones of lower limb

4.05

2.04

1.5

1.1

8.00

16.07

u/l

—

Other factor of the environment

4.04

2.04

1.3

18.17

14.73

u/l

—

Unstable angina pectoris

176

1179

1.24

2.04

1.4

14.37

12.94

u/l

2.04

169

1134

Other predominantly sexually transmitted diseases, not elsewhere classified

246

1.59

2.03

1.6

1.5

11.15

12.23

u/l

0.52

236

Melanocytic naevi, other sites/unspecified

147

1.78

2.02

1.6

1.4

12.42

13.68

u/l

0.39

140

Cramp and spasm

2.06

2.01

1.6

1.3

12.29

13.81

u/l

0.39

Benign neoplasm: Choroid

2.06

2.01

1.4

1.3

12.76

14.58

u/l

0.65

Eating disorder

2.05

2.00

1.4

9.53

11.67

u/l

1.41

Benign neoplasm of eye and adnexa

224

1.61

1.99

1.3

1.5

12.11

13.45

u/l

0.77

214

Delivery, wide proxy

444

0.69

1.99

1.3

1.4

13.47

12.77

u/l

0.23

421

Presbycusis

457

1.42

1.99

1.6

1.4

15.13

13.91

u/l

0.69

443

Nosocomial condition (hospital)

4.63

1.95

1.6

17.60

11.27

u/l

—

Drug-induced systemic lupus erythematosus

4.62

1.95

1.0

1.6

15.00

12.18

u/l

—

Primary ovarian failure

4.57

1.94

1.4

1.1

8.80

14.09

u/l

—

Anosmia

3.31

1.94

1.0

1.3

9.14

11.43

u/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

2.99

1.94

2.3

1.7

16.88

13.48

u/l

—

Behavioural disorders

3.77

1.93

1.0

1.6

10.33

14.13

u/l

—

Chromosomal abnormalities, not elsewhere classified

3.76

1.93

1.8

1.3

14.67

16.37

u/l

—

severe traumatic brain injury, does not include concussion

710

1.33

1.92

1.5

1.4

13.99

13.24

u/l

0.50

683

Fracture of lower leg, including ankle

188

1539

1.22

1.91

1.6

1.4

13.29

12.58

u/l

0.53

177

1494

Retinal detachments and breaks

141

1124

1.26

1.91

1.4

12.89

12.83

u/l

0.03

133

1086

Erosion of teeth, including avohilmo

375

1.44

1.90

1.6

1.4

11.68

11.47

u/l

0.09

364

Pemphigoid

2.17

1.88

2.1

1.3

11.00

14.54

u/l

1.41

Agoraphobia

3.19

1.88

2.0

1.4

9.57

14.55

u/l

—

Other sexually transmitted chlamydial diseases

2.31

1.87

1.1

1.8

11.83

12.98

u/l

0.22

Ptosis of eyelid

268

1.54

1.86

1.4

1.5

11.83

13.35

u/l

1.04

253

Infective dermatitis

260

1.54

1.86

1.4

12.63

13.05

u/l

0.19

250

Excessive, frequent and irregular menstruation

100

421

1.32

1.85

1.8

1.4

11.55

11.95

u/l

0.23

405

Deviated nasal septum

124

978

1.27

1.84

1.4

12.21

12.68

u/l

0.43

118

942

Behavioural disorders, excluding more controls

3.54

1.83

1.0

1.9

10.33

19.00

u/l

—

FESS (DNB20)

253

1.55

1.83

1.5

12.69

12.41

u/l

0.05

243

Hypothyroidism, strict autoimmune, 3 medication purchases required

299

1748

1.17

1.83

1.5

1.4

13.23

12.53

u/l

0.93

291

1690

Unspecified mental disorder

126

997

1.27

1.82

1.3

1.5

10.12

12.37

u/l

4.91

121

965

Single delivery by caesarean section

177

0.52

1.82

1.3

1.6

9.25

11.62

u/l

1.21

172

Parodontitis or/and operation codes

216

1069

1.20

1.82

1.4

12.69

12.27

u/l

0.43

209

1033

Rotator cuff syndrome

234

1466

1.19

1.77

1.4

12.50

12.76

u/l

0.25

223

1416

Carcinoma in situ of skin of other and unspecified parts of face

240

1.55

1.76

1.5

1.4

13.65

14.15

u/l

0.19

226

Other and unspecified vascular occlusions

264

1.52

1.76

1.4

1.5

12.89

13.51

u/l

0.24

247

Unspecific neurodegenerative disorder

130

1119

0.80

1.75

1.3

1.4

14.47

13.43

u/l

0.90

120

1069

Acne

1.90

1.74

1.2

1.5

12.22

12.71

u/l

0.09

Hyperaldosteronism

2.24

1.74

1.2

1.4

14.75

13.20

u/l

0.18

Palmar fascial fibromatosis [Dupuytren]

558

1.35

1.73

1.5

1.4

12.65

13.12

u/l

0.28

533

Acute appendicitis

229

1828

1.18

1.73

1.5

1.4

12.50

12.40

u/l

0.08

224

1768

Postdysenteric arthropathy

3.89

1.72

1.8

1.2

11.20

13.31

u/l

—

Exclusion endpoint for clefts

3.86

1.71

1.0

1.1

14.60

15.85

u/l

—

Benign neoplasm: Skin of lower limb, including hip

2.31

1.71

1.7

1.4

11.55

14.47

u/l

0.76

Family history of malignant neoplasm

156

1.67

1.68

1.7

1.4

9.69

12.05

u/l

2.21

149

Dental caries 2 and operation codes, only avohilmo

163

1228

0.82

1.67

1.5

1.4

11.87

12.24

u/l

0.37

158

1188

Contraceptive management

546

0.72

1.65

1.6

1.4

10.63

11.52

u/l

0.72

530

Benign neoplasm: Transverse colon

285

1.48

1.64

1.5

1.4

12.69

13.27

u/l

0.20

272

Pure hyperglyceridaemia

2.26

1.64

2.0

1.4

13.73

13.70

u/l

0.00

Degenerative conditions of globe

3.64

1.62

1.0

1.6

9.60

16.71

u/l

—

Scleritis

3.60

1.62

1.2

13.20

15.29

u/l

—

Erythema intertrigo

2.34

1.60

1.4

1.3

11.90

13.78

u/l

—

Open wound of forearm

198

1.57

1.59

1.4

14.81

13.53

u/l

0.47

190

Pain and other conditions associated with female genital organs and menstrual cycle

275

1.47

1.58

1.8

1.4

10.60

11.66

u/l

0.84

269

Portal vein thrombosis

2.71

1.58

1.6

1.3

18.29

14.92

u/l

—

Diseases of appendix

248

1941

1.16

1.58

1.5

1.4

12.45

12.46

u/l

0.00

243

1875

Appendicitis, broad definition

246

1931

1.17

1.58

1.5

1.4

12.46

12.44

u/l

0.01

241

1867

Bulimia nervosa (incl. atypical)

2.70

1.58

1.6

1.3

8.57

12.46

u/l

—

Carcinoma in situ of skin of trunk

1.90

1.55

1.7

1.3

14.62

13.79

u/l

0.15

Benign neoplasm: Duodenum

2.12

1.55

1.4

1.3

15.92

13.31

u/l

0.36

Acute alcohol intoxication

753

1.28

1.55

1.3

1.4

12.00

12.87

u/l

0.58

724

Other vitreous opacities

1.93

1.54

1.2

1.4

14.13

13.36

u/l

0.16

Papilloedema, unspecified

2.44

1.54

1.0

1.3

13.50

12.52

u/l

—

Explicit fungal Sepsis

3.38

1.53

1.8

1.7

24.80

12.40

u/l

—

Liposarcoma

3.38

1.53

1.0

1.7

13.40

14.80

u/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

115

1.75

1.52

1.4

1.3

17.20

14.38

u/l

0.61

109

Seborrhoeic keratosis

641

1.30

1.52

1.4

12.68

12.98

u/l

0.17

618

Other specified/unspecified soft tissue disorders

1.83

1.51

1.2

1.4

14.71

13.66

u/l

0.24

Spondylosis

200

1454

1.18

1.51

1.5

1.4

12.88

12.83

u/l

0.04

189

1407

Alzheimer disease, including avohilmo

109

981

0.80

1.50

1.2

1.5

14.10

13.63

u/l

0.33

101

937

Abnormal findings on examination of urine, without diagnosis

101

1.79

1.49

1.8

1.3

12.28

13.92

u/l

0.52

Other salmonella infections

2.01

1.49

1.7

1.4

13.92

13.83

u/l

0.01

Alzheimer disease

878

0.79

1.47

1.2

1.4

14.14

13.75

u/l

0.24

836

Alzheimer’s disease, wide definition

746

0.76

1.45

1.3

1.4

14.48

13.94

u/l

0.29

710

Pregnancy, childbirth and the puerperium

386

0.73

1.44

1.6

1.4

13.93

13.04

u/l

0.28

366

Melanoma in situ of upper limb, including shoulder

3.17

1.44

1.0

1.5

19.60

15.06

u/l

—

Impotence

148

1.63

1.44

1.3

1.4

13.50

12.86

u/l

0.18

142

Other aneurysm

148

1.63

1.44

1.4

16.96

13.72

u/l

1.24

139

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.76

1.44

1.3

1.5

11.83

14.91

u/l

—

Dissocial personality disorder

3.14

1.44

1.8

1.7

11.80

15.63

u/l

—

Pneumoconiosis due to asbestos and other mineral fibres

1.87

1.40

1.4

1.5

12.00

14.29

u/l

1.35

Strabismus

587

1.29

1.39

1.4

1.5

11.99

12.30

u/l

0.21

566

Other neurotic disorders

1.78

1.39

1.3

1.4

13.47

14.20

u/l

0.16

Olecranon bursitis

158

1.59

1.37

1.9

1.4

12.28

12.60

u/l

0.10

152

Disorders of muscles

206

1.51

1.37

1.6

1.4

12.35

13.02

u/l

0.20

197

Unspecified parasitic disease

2.97

1.36

1.8

1.6

12.80

14.00

u/l

—

Other bacterial agents as the cause of diseases classified to other chapters

2.97

1.36

3.0

1.5

13.40

13.53

u/l

—

Cholecystectomy

255

1971

1.14

1.33

1.4

13.67

12.67

u/l

1.63

242

1906

Inguinal hernia, unilateral

2.05

1.33

1.2

1.4

18.82

14.20

u/l

0.33

Inguinal of femoral hernia, unilateral

2.05

1.33

1.2

1.4

18.82

14.20

u/l

0.33

Femoral hernia, unilateral

2.05

1.33

1.2

1.4

18.82

14.20

u/l

0.33

Organic, including symptomatic, mental disorders

216

1345

1.16

1.33

1.3

1.4

13.23

13.27

u/l

0.03

205

1294

Multiple delivery

146

0.48

1.31

1.1

1.7

10.43

11.99

u/l

—

140

Disorders of tooth development and eruption

2.12

1.31

2.1

1.5

9.80

13.46

u/l

—

Benign leiomyoma with endometriosis

284

1.41

1.29

1.4

1.5

12.85

12.20

u/l

0.31

270

Patellar tendinitis

2.79

1.28

1.0

1.7

8.40

14.56

u/l

—

Postprocedural disorders of digestive system, not elsewhere classified

1.94

1.28

1.7

1.4

12.33

13.56

u/l

0.29

Isolated proteinuria

2.01

1.27

1.6

1.4

12.00

14.00

u/l

0.70

Emotional disorders starting during childhood or adolecense, excluding more controls

2.45

1.27

1.2

1.4

9.00

15.50

u/l

—

Juvenile osteochondrosis

2.29

1.27

1.1

1.4

12.75

14.74

u/l

—

Alzheimer’s disease (Late onset)

709

0.77

1.26

1.3

1.4

14.32

13.96

u/l

0.17

673

Other and unspecified visual disturbances

194

1.50

1.26

2.4

1.5

12.59

13.12

u/l

0.15

188

Benign neoplasm: Parotid gland

186

1.51

1.26

1.9

1.4

13.07

13.27

u/l

0.04

176

Selective serotonin reuptake inhibitors

383

1809

1.12

1.24

1.4

12.49

12.89

u/l

0.49

368

1752

Postmenopausal osteoporosis with pathological fracture

100

1.71

1.23

1.8

1.5

12.65

14.04

u/l

0.33

Mental and behavioural disorders due to cannabinoids

2.64

1.21

1.6

1.7

9.20

16.00

u/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.14

1.19

1.4

1.5

9.25

14.22

u/l

—

Meniscus derangement

200

1185

1.16

1.19

1.4

13.05

12.36

u/l

0.84

195

1147

Femoral hernia

109

1.66

1.19

1.3

1.4

16.39

14.06

u/l

0.26

102

Hydrocele

410

1.32

1.18

1.5

1.4

13.06

12.62

u/l

0.23

394

Acute gastritis

165

1.52

1.17

1.7

1.5

14.68

13.48

u/l

0.45

157

Redundant prepuce, phimosis and paraphimosis

541

1.27

1.15

1.4

13.11

12.54

u/l

0.36

524

Other abnormal findings of blood chemistry

1.73

1.15

1.5

1.4

15.47

13.26

u/l

0.40

Acne vulgaris

1.81

1.15

1.0

1.5

10.69

13.08

u/l

0.62

Chalazion

232

1.43

1.14

1.3

1.5

11.55

12.83

u/l

0.70

223

Carcinoma in situ of other and unspecified sites

111

1.63

1.12

1.2

1.4

15.39

13.84

u/l

0.20

105

Carcinoma in situ of skin of scalp and neck

1.79

1.11

1.5

1.4

14.31

13.33

u/l

0.20

Disorders of vitreous body and globe

174

1469

1.16

1.11

1.4

13.72

12.68

u/l

0.99

167

1414

Cerebral aneurysm, nonruptured

168

1.49

1.09

1.1

1.6

11.48

13.05

u/l

0.76

160

Dyshidrosis [pompholyx]

2.39

1.09

1.2

1.4

14.00

14.90

u/l

—

Assault by sharp object

2.39

1.09

1.2

10.80

15.10

u/l

—

Torticollis

2.39

1.09

2.0

1.5

17.60

16.29

u/l

—

Other eating disorders

1.95

1.08

1.5

1.4

9.25

13.24

u/l

—

Hemiplegia

105

1.62

1.06

1.6

1.3

13.41

14.30

u/l

0.17

Mental and behavioural disorders due to opioids

2.13

1.05

1.3

1.6

18.57

15.06

u/l

—

Alzheimer’s disease (Early onset)

124

0.48

1.05

1.2

1.5

12.50

14.34

u/l

—

111

Dermatitis due to ingested food

2.30

1.04

1.2

1.3

14.80

14.00

u/l

—

Benign neoplasm: Tongue

1.97

1.03

1.4

11.67

14.61

u/l

—

Embedded and impacted teeth

281

1.33

1.03

2.0

1.5

12.66

12.04

u/l

0.23

275

Benign neoplasm: salivary glands, exclude unknown (D119)

204

1.43

1.03

2.1

1.4

12.90

13.40

u/l

0.11

194

Desensitization to allergens

1.92

1.02

1.0

1.5

9.11

13.26

u/l

—

Other disorders starting during childhood or adolescence

2.04

1.02

1.4

1.5

9.14

14.71

u/l

—

Pre-eclampsia or poor fetal growth

448

0.73

1.00

1.3

1.4

11.85

11.38

u/l

0.21

432

Extrapyramidal and movement disorders

133

1142

1.17

0.98

1.4

11.91

13.13

u/l

1.75

127

1096

Benign neoplasm: Caecum

283

1.35

0.98

1.5

1.4

14.97

13.17

u/l

0.92

269

Cervical disc disorders

129

1105

1.17

0.98

1.7

1.4

11.93

12.78

u/l

0.95

123

1069

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

692

1.21

0.97

1.5

1.4

11.53

11.92

u/l

0.23

674

Divergent concomitant strabismus

124

1.54

0.96

1.3

1.5

9.58

13.74

u/l

3.33

119

Injuries to the knee and lower leg

421

2210

1.09

0.96

1.5

1.4

12.82

12.62

u/l

0.20

399

2143

Injuries to the elbow and forearm

215

1727

1.13

0.95

1.3

1.4

13.06

12.51

u/l

0.60

209

1668

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

149

1.48

0.95

1.5

1.3

12.86

14.54

u/l

0.73

142

Chronic mastoiditis

1.78

0.94

1.6

1.3

16.73

13.27

u/l

0.64

Complications of labour and delivery

101

669

0.84

0.93

1.5

1.4

10.92

11.74

u/l

0.78

101

648

Leiomyoma of uterus

152

749

1.15

0.93

1.4

12.40

12.17

u/l

0.13

145

723

Benign neoplasm: Kidney

1.72

0.92

1.5

1.4

10.08

13.46

u/l

1.33

Emotional disorders and disorders of social functioning with onset specific to childhood

1.87

0.92

1.1

1.5

10.57

13.95

u/l

—

Abnormal serum enzyme levels

129

1098

1.16

0.92

1.4

13.04

12.98

u/l

0.04

123

1058

Other superficial mycoses

2.15

0.91

2.2

1.4

10.17

16.04

u/l

—

Tooth agenesis EXCLUDE clefts and syndromes

2.15

0.91

1.5

1.3

15.33

12.86

u/l

—

Carcinoma in situ, bladder

102

1.58

0.90

1.3

1.4

15.56

13.70

u/l

0.22

Superficial injury of shoulder and upper arm

244

1.35

0.90

1.5

1.4

12.64

13.39

u/l

0.31

232

Fracture of neck

151

1.46

0.90

1.4

15.68

14.11

u/l

0.30

143

Rubella [German measles]

1.75

0.90

1.5

1.4

11.55

12.22

u/l

0.14

Autonomic disorders

1.87

0.87

1.6

1.4

9.13

14.13

u/l

—

Dystonia

1.58

0.87

1.5

1.4

10.13

14.29

u/l

2.59

Glaucoma

216

1702

1.11

0.84

1.3

1.4

13.79

13.01

u/l

0.72

205

1639

Paralytic ileus

1.60

0.84

1.8

1.3

15.43

13.37

u/l

0.47

Carcinoma in situ of breast, intraductal

1.57

0.84

1.3

11.33

12.09

u/l

0.22

Disorders of vestibular function (Vertigo)

155

1356

1.14

0.84

1.5

1.4

12.41

12.87

u/l

0.46

148

1306

Alzheimer’s disease (Early onset), excluding more controls

105

0.54

0.83

1.2

1.5

12.50

15.35

u/l

—

100

Other intervertebral disc disorders

298

1662

1.10

0.83

1.5

1.4

12.63

12.69

u/l

0.06

287

1610

Benign neoplasm of major salivary glands

240

1.34

0.82

2.0

1.4

12.88

13.33

u/l

0.11

227

Other acquired deformities of musculoskeletal system and connective tissue

1.61

0.81

1.4

13.15

13.93

u/l

0.19

Perforation of tympanic membrane

215

1.35

0.80

1.4

1.5

15.31

13.62

u/l

0.33

206

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

114

1.49

0.79

1.4

1.3

10.71

14.10

u/l

2.56

109

Other secondary gonarthrosis

106

1.51

0.79

1.7

1.4

12.63

13.63

u/l

0.18

100

Injuries to the wrist and hand

327

2180

1.09

0.77

1.5

1.4

12.63

12.60

u/l

0.02

316

2109

Mixed hyperlipidaemia

100

0.50

0.77

1.4

16.20

13.94

u/l

—

Haemorrhoids and perianal venous thrombosis

102

879

1.16

0.76

1.3

1.4

14.58

12.87

u/l

1.62

846

Carcinoma in situ of skin, other sites/unspecified

1.78

0.76

2.5

1.4

16.17

13.31

u/l

—

Synovial cyst of popliteal space [Baker]

157

1.40

0.76

1.5

12.91

13.17

u/l

0.06

149

Benign neoplasm of urinary organs

107

1.50

0.76

1.6

1.4

11.38

13.59

u/l

0.81

100

Papillary adenocarcinoma of thyroid gland

1.57

0.75

1.2

1.4

11.08

13.95

u/l

1.05

Female genital prolapse

363

0.81

0.74

1.4

13.71

12.22

u/l

0.57

347

Diabetes mellitus in pregnancy

263

0.76

0.74

1.3

1.4

11.97

11.09

u/l

0.29

258

Degenerative diseases of the nervous system

114

983

0.87

0.74

1.2

1.4

13.73

13.64

u/l

0.05

108

936

Coxarthrosis, primary

232

1831

1.10

0.74

1.4

13.04

13.03

u/l

0.01

224

1761

Intentional self-harm by sharp object

2.00

0.72

1.2

11.40

15.04

u/l

—

Effects of foreign body entering through natural orifice

625

1.19

0.72

1.4

1.5

12.26

12.63

u/l

0.17

607

Mouth breathing

129

1138

1.13

0.71

1.4

1.5

12.03

12.55

u/l

0.50

122

1101

Dermatographic urticaria

1.51

0.69

1.3

1.5

10.00

12.93

u/l

0.75

Chronic suppurative otitis media, including avohilmo

169

1.36

0.69

1.5

1.4

12.61

13.74

u/l

0.44

160

Malignant neoplasm of stomach

146

0.61

0.69

1.3

1.4

12.33

13.98

u/l

—

135

Adenocarcinoma and ductal carcinoma of pancreas

1.54

0.69

1.3

11.77

14.57

u/l

0.98

Other ill-defined and unspecified causes of mortality

187

1.34

0.68

1.9

1.4

15.36

14.49

u/l

0.22

174

Other and/or unspecified nontoxic goitre

161

1.37

0.68

1.2

1.5

11.14

12.82

u/l

1.19

152

Other appendicitis

161

1.37

0.68

1.8

1.5

11.32

13.27

u/l

1.07

155

Disorders of vitreous body

162

1425

1.11

0.67

1.4

13.96

12.68

u/l

1.24

156

1373

Other noninflammatory disorders of cervix uteri

0.54

0.67

1.0

1.5

12.20

12.49

u/l

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

1.49

0.66

1.6

1.4

13.71

13.31

u/l

0.07

Otosclerosis

179

0.67

0.66

1.4

11.75

13.45

u/l

0.82

173

Obstructed labour due to maternal pelvic abnormality

237

0.72

0.65

1.8

1.4

11.12

11.95

u/l

0.27

224

Urethral stricture

189

1.33

0.64

1.4

1.5

12.72

13.50

u/l

0.28

179

Paranoid personality disorder

1.73

0.64

1.4

1.5

10.40

14.72

u/l

—

Infections of breast associated with childbirth

1.73

0.64

1.4

8.60

12.28

u/l

—

Endometriosis ASRM stages 3,4

386

1.22

0.63

1.5

11.38

12.21

u/l

0.44

370

Use of selegiline

131

0.61

0.63

1.9

1.4

10.50

13.80

u/l

—

123

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

291

0.76

0.62

1.6

1.5

12.50

12.53

u/l

0.01

281

Other peripheral vascular diseases

156

1.35

0.61

1.4

13.48

13.23

u/l

0.06

150

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.48

0.60

1.2

1.4

11.62

13.66

u/l

0.95

Impingement syndrome of shoulder

694

1.15

0.60

1.4

12.41

12.39

u/l

0.01

672

Excessive vomiting in pregnancy

105

1.43

0.60

2.9

1.5

9.47

12.41

u/l

1.99

100

Other specified and unspecified retinal disorders

1.50

0.60

1.4

10.83

13.41

u/l

0.82

Melanocytic naevi of eyelid, including canthus

0.00

0.59

0.0

1.1

—

14.05

—

Deep endometriosis

131

1.38

0.59

1.6

1.7

10.28

12.59

u/l

1.10

125

Melanocytic naevi of lower limb, including hip

1.57

0.58

1.6

1.4

11.00

13.84

u/l

—

Long labour

277

1.23

0.58

1.3

1.5

11.92

11.27

u/l

0.23

268

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

231

0.74

0.58

2.1

1.5

10.47

11.57

u/l

0.45

222

Disorders of breast

104

856

1.13

0.56

1.4

11.27

12.16

u/l

0.85

827

Other hammer toe(s) (acquired)

411

1.19

0.56

1.5

1.4

12.65

12.45

u/l

0.08

397

Premature rupture of membranes

202

0.76

0.55

1.2

1.4

11.10

11.68

u/l

0.15

197

Other disorders of the genitourinary system

284

1.23

0.55

2.3

1.5

14.60

12.80

u/l

0.48

269

Benign neoplasm: Anus and anal canal

1.50

0.54

1.4

13.11

13.89

u/l

—

Systemic atrophies primarily affecting the central nervous system

1.42

0.54

1.3

11.79

13.77

u/l

0.70

Endometriosis of ovary

293

1.23

0.54

1.7

1.4

11.44

12.18

u/l

0.30

284

Emotional disorders starting during childhood or adolescence

1.57

0.54

1.2

1.6

9.00

14.37

u/l

—

Carcinoma in situ of other and unspecified digestive organs

1.46

0.53

1.1

1.3

11.56

14.66

u/l

—

Hyperkinetic disorders, excluding more controls

1.49

0.53

1.5

1.4

8.73

13.06

u/l

2.77

Viral haemorrhagic fevers, not elsewhere classified/unspecified

169

1.30

0.53

1.1

1.5

12.59

13.14

u/l

0.18

162

Anankastic personality disorder

1.54

0.53

1.7

1.5

13.67

13.05

u/l

—

Varicella [chickenpox]

1.45

0.53

1.3

1.4

11.56

12.29

u/l

—

Other maltreatment syndromes

1.50

0.51

1.0

1.6

8.83

13.05

u/l

—

Pre-eclampsia

315

0.79

0.51

1.4

1.5

11.56

11.39

u/l

0.06

302

Other specified disorders of kidney and ureter

1.41

0.51

1.2

1.4

21.44

13.02

u/l

—

Parkinson's disease

500

0.84

0.51

1.6

1.4

12.38

13.19

u/l

0.57

475

Parkinson's disease, strict definition

467

0.83

0.50

1.6

1.4

12.72

13.11

u/l

0.22

442

Other puerperal infections

1.47

0.50

1.3

1.9

13.36

11.65

u/l

0.37

Endometriosis of pelvic peritoneum

248

1.23

0.50

1.7

1.4

10.61

11.89

u/l

0.68

240

Malignant neoplasm of endocrine gland

127

1.34

0.49

1.2

1.4

11.06

13.81

u/l

1.50

119

Ill-defined and unknown causes of mortality

216

1.25

0.49

1.9

1.4

14.74

14.39

u/l

0.08

201

Pre-eclampsia or eclampsia

345

0.81

0.48

1.4

1.5

11.93

11.56

u/l

0.14

331

Paralytic strabismus

163

1.29

0.48

1.2

1.5

14.38

13.65

u/l

0.23

156

Endovascular or surgical operations to intracerebral aneurysms

119

1.35

0.48

1.3

1.5

10.94

13.61

u/l

1.40

114

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

149

1113

1.09

0.48

1.4

11.34

12.35

u/l

1.55

144

1077

Parkinson's disease, including avohilmo

528

0.85

0.47

1.6

1.4

12.82

12.99

u/l

0.08

503

Dental caries 2, only avohilmo

174

1486

0.92

0.47

1.5

1.4

11.83

12.08

u/l

0.23

169

1444

Adenocarcinoma and papillary adenocarcinoma of stomach

0.60

0.45

1.0

1.4

11.20

13.92

u/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

138

1.31

0.45

1.1

1.6

8.22

12.08

u/l

2.81

133

False labour

229

0.82

0.44

1.2

1.4

9.97

11.27

u/l

0.92

224

Congenital malformations of eye, ear, face and neck

1.40

0.44

1.3

1.4

10.67

13.89

u/l

1.16

Other congenital malformations

112

1.34

0.44

1.3

1.4

13.00

13.58

u/l

0.11

106

Other intracranial haemorrhages

1.37

0.44

1.2

1.4

16.62

14.31

u/l

0.46

Preterm labour and delivery

405

0.84

0.43

1.1

1.4

11.03

11.37

u/l

0.11

388

Other menopausal disorders

315

0.86

0.43

1.6

1.4

10.13

11.85

u/l

1.47

305

Melanocytic naevi of other and unspecified parts of face

104

1.35

0.43

1.9

1.4

9.86

13.13

u/l

1.64

Exposure to other and unspecified animate mechanical forces

1.56

0.42

1.8

1.3

10.60

15.13

u/l

—

Abnormal findings on antenatal screening of mother

0.64

0.42

1.7

1.5

8.67

11.14

u/l

—

Infections of genitourinary tract in pregnancy

131

1.30

0.42

1.6

1.5

12.88

12.01

u/l

0.15

125

Adenocarcinoma of pancreas

1.43

0.42

1.4

1.3

11.00

14.40

u/l

—

Impacted cerumen

258

1.20

0.41

1.6

1.5

13.19

13.50

u/l

0.10

246

Coxarthrosis, primary, with hip surgery

178

1571

1.07

0.41

1.4

12.68

13.10

u/l

0.40

173

1508

Dementia

153

1141

0.92

0.41

1.3

1.4

13.55

13.38

u/l

0.12

143

1093

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.00

0.41

0.0

1.3

—

13.88

—

Benign paroxysmal vertigo

775

1.11

0.41

1.5

12.75

12.90

u/l

0.08

742

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.41

0.0

1.6

—

14.18

—

Endometriosis ASRM stages 1,2

268

1.19

0.40

1.7

1.5

10.41

11.52

u/l

0.59

259

LSIL lesion of the cervix uteri

138

0.72

0.40

1.5

1.6

15.10

11.71

u/l

—

133

Benign neoplasm of other and unspecified sites

1.34

0.40

1.1

1.4

11.88

12.62

u/l

—

Retinal breaks without detachment

390

1.15

0.39

1.5

1.4

12.29

12.12

u/l

0.06

376

Use of levodopa decarboxylase inhibitor

442

0.86

0.38

1.5

12.55

13.26

u/l

0.30

420

Postpartum haemorrhage

282

0.83

0.38

2.2

1.4

10.85

10.97

u/l

0.04

275

Benign neoplasm: Choroid

134

1.27

0.37

1.4

12.76

13.85

u/l

0.34

126

Other secondary coxarthrosis

1.29

0.36

1.3

1.4

12.11

13.61

u/l

—

Malignant neoplasm of oral cavity

1.36

0.36

1.2

1.4

12.64

13.85

u/l

0.22

Dental pulpitis 3

1.31

0.36

1.4

1.3

10.79

12.10

u/l

0.32

Primary open-angle glaucoma

117

1053

1.08

0.35

1.3

1.4

14.58

13.27

u/l

0.78

112

1006

Dementia, including avohilmo

165

1215

0.94

0.35

1.3

1.4

13.24

13.45

u/l

0.16

155

1165

Ménière disease

236

1.19

0.34

1.4

1.5

12.61

13.47

u/l

0.39

226

Other diseases of peritoneum

1.34

0.34

1.7

1.4

11.55

13.47

u/l

0.64

Chronic suppurative otitis media

154

1.24

0.33

1.6

1.4

13.00

13.81

u/l

0.24

145

Other obstructed labour

100

1.30

0.33

1.2

1.4

11.92

11.95

u/l

0.00

Other osteochondropathies

127

1.26

0.33

1.8

1.4

14.62

13.58

u/l

0.17

121

Benign neoplasm of ovary

313

1.15

0.32

1.3

1.5

15.44

12.53

u/l

0.80

298

Malignant neoplasm of thyroid gland

119

1.26

0.31

1.3

1.4

10.87

13.84

u/l

1.47

112

Spontaneous abortion

559

0.91

0.31

1.4

1.5

11.09

11.72

u/l

0.45

542

Type1 diabetes, definitions combined, early onset

1.34

0.31

1.6

1.5

20.00

12.83

u/l

—

Diseases of inner ear

176

1627

1.06

0.31

1.4

12.56

12.76

u/l

0.17

169

1570

Injury of muscle and tendon at hip and thigh level

193

1.19

0.30

1.8

1.5

13.39

12.45

u/l

0.34

187

Otitis media, unspecified

144

1.22

0.30

1.5

16.74

12.99

u/l

1.00

139

Foreign body or object entering through skin

111

1.26

0.30

1.4

10.43

13.94

u/l

1.98

106

Injury of muscle and tendon at lower leg level

409

0.88

0.29

1.3

1.4

11.35

12.69

u/l

0.88

399

Postpartum hemorraghe, all women as controls

312

0.86

0.29

2.2

1.4

10.85

11.13

u/l

0.11

305

Psychotic depression

108

0.74

0.29

1.3

1.5

15.63

14.20

u/l

—

101

Fall on and from ladder

195

0.82

0.28

1.3

1.4

9.88

13.13

u/l

1.89

186

Other disorders of penis

270

1.15

0.28

1.6

1.4

13.55

12.60

u/l

0.49

260

Vasomotor rhinitis (mode)

149

1.21

0.27

3.2

1.4

13.22

13.35

u/l

0.03

141

Hyperkinetic disorders

1.29

0.27

1.5

1.7

8.73

12.32

u/l

2.32

Dental caries 2

184

1522

0.95

0.27

1.5

1.4

12.06

12.10

u/l

0.04

178

1479

Any dementia, excluding more controls

142

928

1.06

0.27

1.3

1.4

12.87

13.62

u/l

0.79

132

886

Other peripheral vertigo

215

1.16

0.26

1.3

1.5

12.00

13.46

u/l

0.71

206

Endometriosis of rectovaginal septum and vagina

132

1.21

0.25

1.2

1.5

10.06

12.24

u/l

0.97

127

Dental caries 2 and operation codes

179

1493

0.95

0.25

1.5

1.4

12.10

12.09

u/l

0.01

173

1452

Atrophic disorders of skin

254

1.14

0.25

1.8

1.4

11.55

12.68

u/l

0.48

242

Disturbance of activity and attention

1.18

0.24

1.6

1.7

8.11

12.19

u/l

—

Other/unspecified disorders of vestibular function

1.28

0.24

1.7

1.4

16.00

13.97

u/l

—

Total colectomy operation

1.28

0.24

1.7

1.5

11.00

13.60

u/l

—

Total colectomy

1.28

0.24

1.7

1.5

11.00

13.60

u/l

—

Gonarthrosis,primary

328

1992

1.04

0.24

1.5

1.4

13.13

12.81

u/l

0.37

319

1913

Cervicocranial syndrome

208

1.15

0.24

1.6

1.4

13.63

12.94

u/l

0.19

201

Pedal cyclist injured in transport accident

485

0.91

0.23

2.1

1.5

12.02

12.48

u/l

0.22

470

Varicose veins

216

1565

1.04

0.23

1.5

1.4

13.71

12.73

u/l

1.18

205

1513

Ingrowing nail

1.27

0.22

1.6

1.3

13.60

13.64

u/l

—

Fenamates

321

1.09

0.22

1.7

1.5

13.02

12.96

u/l

0.02

307

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

1.22

0.22

1.0

1.2

11.20

16.53

u/l

—

Pedestrian injured in transport accident

135

0.81

0.22

3.8

1.4

15.09

13.95

u/l

0.17

128

Dental pulpitis 3, only avohilmo

1.23

0.21

1.2

1.4

10.58

11.77

u/l

0.24

Adenocarcinoma of small intestine

0.00

0.21

0.0

1.9

—

14.40

—

Cerebral amyloid angiopathy

0.00

0.21

0.0

1.7

—

14.10

—

Injury of blood vessels of thorax

0.00

0.21

0.0

1.3

—

17.40

—

Psoas tendinitis

0.00

0.21

0.0

1.7

—

14.00

—

Chromophobe cell carcinoma of kidney

0.00

0.21

0.0

1.7

—

13.70

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.7

—

14.27

—

Other disorders of carbohydrate metabolism

0.00

0.21

0.0

1.8

—

13.10

—

Other specified/unspecified diseases of inner ear

0.00

0.21

0.0

1.4

—

17.50

—

Malignant neoplasm of base of tongue

0.00

0.21

0.0

1.2

—

17.80

—

Defect, injury or illness of neck

0.00

0.21

0.0

1.7

—

13.40

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.21

0.0

1.7

—

13.64

—

Carcinoma in situ of breast, lobular

0.00

0.21

0.0

1.2

—

11.91

—

Disorder of pancreatic internal secretion, other and/or unspecified

0.00

0.21

0.0

1.7

—

12.55

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.7

—

15.90

—

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

17.80

—

Frostbite

0.00

0.21

0.0

1.3

—

14.91

—

Other disorders of binocular vision

0.00

0.21

0.0

1.0

—

18.70

—

Artrosis, including avohilmo

309

1640

1.03

0.21

1.5

1.4

12.38

12.67

u/l

0.35

300

1581

Maternal care for known or suspected abnormality of pelvic organs

225

0.89

0.21

1.3

1.4

10.52

11.52

u/l

0.56

217

Senile degeneration of the brain, not elsewhere classified

0.00

0.21

0.0

1.8

—

15.58

—

Evidence of alcohol involvement determined by level of intoxication

0.00

0.21

0.0

1.8

—

16.33

—

0.00

0.21

0.0

1.2

—

13.83

—

Frontotemporal dementia

0.00

0.21

0.0

1.5

—

15.23

—

Striking against or struck by other objects

789

1.06

0.20

1.4

1.5

12.47

12.41

u/l

0.02

767

Benign neoplasm: Eye, unspecified

0.00

0.20

0.0

1.6

—

13.86

—

Pregnancy hypertension

600

0.93

0.19

1.3

1.5

11.87

11.52

u/l

0.17

583

Other/unspecified synovitis and tenosynovitis

241

1.12

0.19

1.7

1.4

11.11

12.67

u/l

0.99

231

Carpal tunnel syndrome

180

1564

1.04

0.18

1.4

13.38

12.47

u/l

0.93

174

1521

Artificial joint re-operation

164

0.85

0.18

1.6

1.4

13.64

13.06

u/l

0.18

155

Pedal cyclist injured in other and unspecified transport accidents

223

1.12

0.18

1.4

12.64

13.13

u/l

0.16

216

Left hemicolectomy

1.17

0.18

1.4

15.57

13.81

u/l

—

Burns and corrosions of external body surface, specified by site

214

1.12

0.17

1.3

1.5

13.04

13.21

u/l

0.04

206

Other disorders of breast

195

1.13

0.17

1.3

1.6

9.41

12.10

u/l

2.37

187

Spontaneous rupture of synovium and tendon

176

1.14

0.17

1.2

1.5

13.55

12.91

u/l

0.14

169

Other deformities of toe(s)

0.76

0.17

1.0

1.4

13.20

13.66

u/l

—

Cholesteatoma of middle ear

141

0.85

0.16

1.3

1.4

13.83

13.74

u/l

0.01

132

Uterine polyps

169

1.12

0.14

1.4

1.5

11.63

12.60

u/l

0.21

163

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.78

0.14

1.3

13.29

13.80

u/l

—

Use of ropinirole

0.82

0.13

1.6

1.4

13.00

13.11

u/l

—

Injury of eye and orbit

274

0.91

0.13

1.5

11.16

12.41

u/l

0.66

268

Anti-inflammatory and antirheumatic products, non-steroids

112

541

1.04

0.13

1.4

1.5

13.96

13.39

u/l

0.36

105

521

Urolithiasis

106

1100

0.96

0.12

1.6

1.4

13.77

12.79

u/l

0.94

100

1063

Pterygium

1.18

0.12

1.6

1.4

10.50

14.42

u/l

—

Hordeolum and other deep inflammation of eyelid

1.18

0.12

1.8

1.4

12.50

14.15

u/l

—

Mixed conductive and sensorineural hearing loss

317

1.07

0.12

1.3

1.4

12.21

13.17

u/l

0.53

305

Triptan medication for migraine, single purchase ok

180

1186

1.03

0.11

1.6

1.4

11.39

11.92

u/l

0.54

175

1160

Migraine, single triptan purchase ok & required. ICD-code if available is included

180

1186

1.03

0.11

1.6

1.4

11.39

11.92

u/l

0.54

175

1160

Retained placenta and membranes, without haemorrhage

191

1.10

0.11

1.3

1.4

11.10

11.48

u/l

0.10

181

Burns and corrosions

288

1.08

0.11

1.3

1.5

12.87

12.72

u/l

0.04

278

Polyp of the female genital tract

378

1.05

0.11

1.3

1.4

11.93

12.10

u/l

0.08

362

Parkinson's disease, strict definition, excluding more controls

405

0.94

0.10

1.6

1.4

12.72

13.23

u/l

0.29

393

Gestational [pregnancy-induced] hypertension

377

1.06

0.10

1.3

1.5

11.95

11.10

u/l

0.34

365

Glaucoma suspect

111

1077

1.03

0.10

1.4

13.31

13.05

u/l

0.12

105

1030

Glucosamine medication

173

1349

1.02

0.09

1.6

1.4

13.05

13.01

u/l

0.03

165

1294

Parkinson's disease, excluding more controls

431

0.95

0.09

1.6

1.4

12.38

13.21

u/l

0.56

417

Pedal cyclist injured in noncollision transport accidents

217

0.92

0.09

2.7

1.5

11.00

13.00

u/l

0.92

210

Other and unspecified abdominal hernia

1.14

0.09

1.2

1.4

11.55

14.01

u/l

0.67

Carcinoma in situ of cervix uteri

1.13

0.09

1.0

1.8

10.09

12.01

u/l

0.96

Other noninflammatory disorders of vagina

126

1.11

0.09

1.9

1.4

12.21

11.98

u/l

0.04

121

Peripheral retinal degeneration

1.03

0.08

1.3

1.4

13.83

13.21

u/l

—

Pedestrian injured in collision with pedal cycle

0.82

0.08

6.8

1.3

16.80

14.30

u/l

—

Undefined dementia

350

1.05

0.08

1.3

1.4

11.66

14.59

u/l

3.09

329

Dementia due to Parkinson's disease

0.86

0.07

1.3

1.4

11.83

14.31

u/l

—

Dislocation, sprain and strain of joint and ligaments of hip

0.83

0.07

1.0

1.4

15.50

14.07

u/l

—

Hypertrophy of breast

266

0.94

0.07

1.4

1.5

11.16

11.84

u/l

0.30

257

Laparoscopic right hemicolectomy

143

0.91

0.07

1.4

13.46

13.79

u/l

0.08

136

Type 1 diabetes, strict definition, subgroup 1

1.02

0.07

1.5

1.4

18.75

11.77

u/l

—

Prolapse and hernia of ovary and fallopian tube

0.84

0.07

1.1

1.4

16.29

12.95

u/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

206

1.07

0.07

1.6

1.4

12.50

12.60

u/l

0.03

198

Lichen sclerosus et atrophicus

158

1.08

0.06

1.9

1.5

13.18

13.03

u/l

0.03

150

Conductive hearing loss, unspecified

172

0.93

0.06

1.2

1.4

12.31

13.58

u/l

0.37

166

Fall on same level involving ice and snow

160

1624

0.99

0.05

1.6

1.4

13.93

12.57

u/l

1.59

152

1570

malignant neoplasm of male genital organs

189

1184

1.01

0.05

1.4

12.75

13.33

u/l

0.66

181

1139

Artificial joint operation, meniscal resection

318

2096

1.01

0.04

1.6

1.4

12.79

12.83

u/l

0.04

311

2018

Lumbar disc prolapse

195

1533

1.01

0.04

1.5

1.4

12.80

12.55

u/l

0.23

188

1488

Malignant neoplasm of pancreas

180

1.06

0.04

1.5

1.4

12.11

14.02

u/l

0.92

170

Maternal care related to the fetus and amniotic cavity and possible delivery problems

397

0.98

0.04

1.7

1.4

11.86

11.33

u/l

0.24

382

Inflammatory disease of uterus

200

1.05

0.03

1.3

1.6

11.67

11.71

u/l

0.01

192

Malignant neoplasm of liver and intrahepatic bile ducts

102

1.08

0.03

1.5

17.73

13.83

u/l

1.02

Malignant neoplasm of prostate

187

1171

1.01

0.02

1.4

12.73

13.34

u/l

0.70

179

1126

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

142

1.06

0.02

1.5

1.4

12.80

13.43

u/l

0.15

136

Unspecified dementia

352

1.02

0.02

1.3

1.4

11.66

14.38

u/l

2.76

332

Any dementia

150

1049

1.01

0.01

1.3

1.5

13.03

13.52

u/l

0.47

139

1003

Lesion of sciatic nerve

133

1.05

0.01

1.4

16.36

13.69

u/l

0.48

126

Nontoxic single thyroid nodule

137

0.95

0.01

1.3

1.5

9.77

12.67

u/l

1.32

132

Disorders of synovium and tendon

144

1306

0.99

0.01

1.6

1.4

11.59

12.39

u/l

0.98

139

1264

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

167

0.96

0.01

1.6

1.4

12.31

13.37

u/l

0.25

159

Intracerebral haemorrhage

383

1.02

0.01

1.3

1.5

12.85

13.56

u/l

0.38

368

Early lumbar disc prolapse, operated

126

0.95

0.00

1.5

9.17

12.67

u/l

2.13

126

Carcinoma in situ of breast, intraductal

144

1.04

0.00

1.3

1.4

11.33

12.29

u/l

0.28

136

Superficial injury of forearm

174

1.03

0.00

1.4

1.5

12.67

13.39

u/l

0.21

168

Ectopic pregnancy

287

1.01

0.00

1.3

1.5

12.24

11.54

u/l

0.30

274

Haemorrhage in early pregnancy

440

1.00

0.00

1.3

1.4

9.89

11.33

u/l

1.20

425

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

141

0.99

0.00

1.4

16.14

13.79

u/l

0.63

131

LSIL lesion of the cervix uteri, vagina or vulva

184

0.98

0.00

1.5

1.6

13.44

11.57

u/l

0.37

177

Calculus of kidney and ureter

992

1.00

0.00

1.6

1.4

13.88

12.75

u/l

1.08

956

Malignant neoplasm of bladder

251

1.00

0.00

1.5

1.4

13.24

13.48

u/l

0.09

233

Other rupture of muscle

0.00

0.0

1.8

—

14.33

—

Delayed milestone in childhood

0.00

0.0

1.0

—

17.71

—

Merkel cell carcinoma of skin

0.00

0.0

2.4

—

10.20

—

Other sudden death, cause unknown

0.00

0.0

2.0

—

15.13

—

Bradycardia, unspecified, drug-induced

0.00

0.0

1.3

—

14.38

—

Carcinoma in situ of larynx

0.00

0.0

2.0

—

15.67

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.0

1.1

—

11.00

—

Qualitative platelet defects

0.00

0.0

1.0

—

16.00

—

Use of pergolide

0.00

0.0

2.1

—

15.43

—

Injury of blood vessels at neck level

0.00

0.0

1.3

—

18.50

—

Unspecified transport accident

0.00

0.0

1.1

—

16.00

—

Contact with other and unspecified heat and hot substances

0.00

0.0

1.3

—

13.17

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.0

1.9

—

11.67

—

Phantom limb syndrome with pain

0.00

0.0

2.2

—

12.80

—

Malignant neoplasm of other and unspecified urinary organs

0.00

0.0

1.9

—

13.33

—

Nonadministration of surgical and medical care

0.00

0.0

1.4

—

16.40

—

Brain astrocytoma

0.00

0.0

1.2

—

20.80

—

Marfan's syndrome

0.00

0.0

1.2

—

13.50

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.9

—

14.56

—

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

15.40

—

Fat embolism (traumatic)

0.00

0.0

1.2

—

21.00

—

Contact urticaria

0.00

0.0

2.0

—

15.17

—

Benign intracranial hypertension

0.00

0.0

1.0

—

16.60

—

Chronic myringitis

0.00

0.0

1.8

—

11.78

—

Carcinoma in situ of oral cavity and pharynx

0.00

0.0

1.2

—

14.80

—

Toxic effect of organic solvents

0.00

0.0

1.4

—

17.60

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

2.2

—

13.40

—

Osteolysis

0.00

0.0

1.0

—

20.20

—

Unspecified pneumoconiosis

0.00

0.0

1.3

—

13.17

—

Disorders of aromatic amino-acid metabolism

0.00

0.0

2.0

—

13.43

—

Calcium deposit in bursa

0.00

0.0

1.2

—

15.20

—

Type 1 diabetes, strict definition

0.91

0.00

1.5

1.4

18.75

12.25

u/l

—

Small kidney of unknown cause

0.00

0.0

1.3

—

14.33

—

Eccrine sweat disorders

0.00

0.0

1.2

—

13.20

—

Injury of blood vessels at hip and thigh level

0.00

0.0

1.2

—

14.60

—

Use of dimethyl fumarate

0.00

0.0

1.5

—

17.00

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.3

—

13.17

—

Other superficial injuries of ankle and foot

0.00

0.0

1.2

—

17.17

—

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

24.20

—

Phantom limb syndrome

0.00

0.0

2.2

—

15.80

—

Open wounds involving multiple body regions

0.00

0.0

1.2

—

14.60

—

Other and unspecified injuries of forearm

0.00

0.0

1.3

—

14.50

—

Toxic encephalopathy

0.00

0.0

1.3

—

15.33

—

Toxic effect of contact with venomous animals

0.98

0.00

1.5

1.4

8.67

12.91

u/l

—

Traumatic subcutaneous emphysema

0.00

0.0

1.4

—

13.40

—

Superficial frostbite

0.00

0.0

1.3

—

14.29

—

Use of bromocriptine

0.00

0.0

1.2

—

16.00

—

Benign neoplasm: Pancreas

0.89

0.00

1.0

1.4

15.20

14.35

u/l

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.1

—

13.43

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

0.0

1.0

—

11.20

—

Use of trihexyphenidyl

0.00

0.0

1.4

—

18.40

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.0

2.2

—

11.50

—

Other congenital malformations of male genital organs

0.00

0.0

1.0

—

19.50

—

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

16.67

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.2

—

14.33

—

Testicular dysfunction, other/unspecified

0.00

0.0

1.9

—

14.12

—

Other acantholytic disorders

0.00

0.0

2.1

—

12.14

—

Non-seminoma of testis

0.00

0.0

1.3

—

16.14

—

Acute inflammation of orbit

0.00

0.0

1.3

—

17.00

—

Mandibular hypoplasia

0.00

0.0

1.2

—

16.50

—

Mastocytosis

0.00

0.0

2.0

—

12.71

—

Discharge from other and unspecified firearms

0.00

0.0

1.8

—

18.67

—

Palatinal maxillary canine

0.00

0.0

1.0

—

10.60

—

Unspecified organic or symptomatic mental disorder

0.00

0.0

1.3

—

15.00

—

Carcinoma in situ of penis

0.00

0.0

2.4

—

15.60

—

Malignant neoplasm of accessory sinuses

0.00

0.0

1.2

—

13.20

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.0

1.0

—

12.50

—

Benign lipomatous neoplasm of spermatic cord

0.00

0.0

1.4

—

14.40

—

Respiratory distress of newborn

0.00

0.0

1.0

—

15.00

—

Lesion of medial popliteal nerve

0.00

0.0

2.2

—

10.67

—

Use of teriflunomide

0.00

0.0

1.2

—

15.17

—

Impacted maxillary canine

0.00

0.0

1.9

—

10.86

—

Transient acantholytic dermatosis [Grover]

0.00

0.0

2.1

—

12.14

—

Benign neoplasm: other/unspecified salivary gland

0.93

0.00

2.4

1.3

11.20

14.48

u/l

—

Other benign neoplasm of uterus: Cervix uteri

0.00

0.0

1.0

—

11.56

—

Palatinal maxillary operation

0.00

0.0

1.0

—

10.50

—

Hypospadias

0.00

0.0

1.3

—

17.29

—

Other cestode infections

0.00

0.0

1.3

—

15.71

—

Family history of other conditions

0.00

0.0

1.1

—

14.71

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.0

1.0

—

17.60

—

Injury of blood vessels at forearm level

0.00

0.0

2.3

—

12.17

—

Generalized pustular psoriasis

0.00

0.0

2.3

—

13.33

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS